| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX19B DNAH3 MYO5A ERCC6L MYO7A SMC1A MCM6 ZNFX1 RFC3 ARID1A ZRANB3 MYO5C LONP1 SMC3 NAV3 HELZ DNAH5 DNAH9 DYNC1H1 | 5.58e-07 | 614 | 161 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.18e-06 | 118 | 161 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.14e-05 | 18 | 161 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | PH domain binding | 4.17e-05 | 9 | 161 | 3 | GO:0042731 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 7.17e-05 | 28 | 161 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.95e-05 | 130 | 161 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 2.19e-04 | 37 | 161 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX19B DNAH3 ERCC6L SMC1A MCM6 RFC3 LONP1 SMC3 NAV3 DNAH5 DNAH9 DYNC1H1 | 2.49e-04 | 441 | 161 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.54e-04 | 70 | 161 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | helicase activity | 2.99e-04 | 158 | 161 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | mediator complex binding | 3.84e-04 | 4 | 161 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM4 CLSTN3 ANK1 OFD1 MYO5A MYO7A SPTBN1 TRPC5 TOM1 DAXX MYO5C TIAM1 SMC3 PHACTR4 NAV3 CEP295 RAB39B FERMT2 AGBL1 FRMD5 | 5.55e-04 | 1099 | 161 | 20 | GO:0008092 |
| GeneOntologyCellularComponent | supramolecular fiber | TPM4 CUL3 COL5A2 DNAH3 KRT12 ANK1 MYO5A DSP KRT35 MYOD1 SPTBN1 DAXX LMNB2 PPL NEK2 LMNB1 TIAM1 PDE4DIP NAV3 KRT20 CEP295 FERMT2 DNAH5 DNAH9 KRT36 DYNC1H1 | 1.04e-06 | 1179 | 160 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM4 CUL3 COL5A2 DNAH3 KRT12 ANK1 MYO5A DSP KRT35 MYOD1 SPTBN1 DAXX LMNB2 PPL NEK2 LMNB1 TIAM1 PDE4DIP NAV3 KRT20 CEP295 FERMT2 DNAH5 DNAH9 KRT36 DYNC1H1 | 1.18e-06 | 1187 | 160 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM4 CUL3 DNAH3 KRT12 MYO5A DSP KRT35 DAXX LMNB2 PPL NEK2 LMNB1 TIAM1 PDE4DIP NAV3 KRT20 CEP295 DNAH5 DNAH9 KRT36 DYNC1H1 | 5.32e-06 | 899 | 160 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | nuclear periphery | 5.29e-05 | 171 | 160 | 8 | GO:0034399 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 5.47e-05 | 276 | 160 | 10 | GO:0000775 | |
| GeneOntologyCellularComponent | intermediate filament | 6.53e-05 | 227 | 160 | 9 | GO:0005882 | |
| GeneOntologyCellularComponent | nuclear chromosome | 1.53e-04 | 254 | 160 | 9 | GO:0000228 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 1.99e-04 | 263 | 160 | 9 | GO:0045111 | |
| GeneOntologyCellularComponent | chromocenter | 3.30e-04 | 18 | 160 | 3 | GO:0010369 | |
| GeneOntologyCellularComponent | nuclear envelope | DDX19B NEMP1 TENT4A CBX3 BCHE LMNB2 BROX LMNB1 CBX5 RBM15B NAV3 ALOX5 DYNC1H1 | 3.86e-04 | 560 | 160 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | chromosomal region | ERCC6L SMC1A CBX3 MCM6 DAXX SEPTIN6 NEK2 SMC3 CBX5 BUB1B CBX1 | 4.11e-04 | 421 | 160 | 11 | GO:0098687 |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 7.29e-04 | 193 | 160 | 7 | GO:0000779 | |
| GeneOntologyCellularComponent | nuclear matrix | 7.39e-04 | 140 | 160 | 6 | GO:0016363 | |
| GeneOntologyCellularComponent | dynein complex | 7.76e-04 | 54 | 160 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | lamin filament | 8.56e-04 | 6 | 160 | 2 | GO:0005638 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 8.94e-04 | 25 | 160 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | spindle | CUL3 SMC1A CBX3 NSUN2 SEPTIN6 NEK2 SMC3 BUB1B CBX1 PRPF19 CEP295 | 1.04e-03 | 471 | 160 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | meiotic cohesin complex | 1.19e-03 | 7 | 160 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 1.19e-03 | 7 | 160 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | cell leading edge | ANK1 MYO5A SPTBN1 TIAM1 PIK3CA PHACTR4 PRKCI ATF4 PLD1 FERMT2 SH3BGRL3 | 1.67e-03 | 500 | 160 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | pericentric heterochromatin | 1.85e-03 | 32 | 160 | 3 | GO:0005721 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.02e-03 | 9 | 160 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | cell cortex | 2.28e-03 | 371 | 160 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.43e-03 | 238 | 160 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | centrosome | CUL3 FAM184A OFD1 CCDC18 CDH23 PPP4R3A CCDC13 NEK2 TIAM1 PDE4DIP BUB1B CEP295 ATF4 DYNC1H1 | 2.43e-03 | 770 | 160 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | condensed chromosome | 2.57e-03 | 307 | 160 | 8 | GO:0000793 | |
| GeneOntologyCellularComponent | microtubule | CUL3 DNAH3 DAXX NEK2 TIAM1 PDE4DIP NAV3 CEP295 DNAH5 DNAH9 DYNC1H1 | 2.73e-03 | 533 | 160 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | kinetochore | 2.74e-03 | 181 | 160 | 6 | GO:0000776 | |
| GeneOntologyCellularComponent | transferase complex | CUL3 PNKP OGT ACACB POLE ZNFX1 FBXO17 DPM1 SOCS2 PIK3CA CBX5 CSNK2A1 BUB1B PKLR RBM15B PRKCI | 2.98e-03 | 963 | 160 | 16 | GO:1990234 |
| GeneOntologyCellularComponent | unconventional myosin complex | 3.06e-03 | 11 | 160 | 2 | GO:0016461 | |
| GeneOntologyCellularComponent | cohesin complex | 3.06e-03 | 11 | 160 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | stereocilium bundle | 3.18e-03 | 79 | 160 | 4 | GO:0032421 | |
| Domain | ChSh | 6.05e-07 | 3 | 159 | 3 | SM00300 | |
| Domain | Chromo_shadow_dom | 6.05e-07 | 3 | 159 | 3 | IPR008251 | |
| Domain | Chromo_shadow | 6.05e-07 | 3 | 159 | 3 | PF01393 | |
| Domain | P-loop_NTPase | DDX19B DNAH3 PNKP MYO5A ERCC6L MYO7A SMC1A MCM6 ZNFX1 GIMAP7 RFC3 ZRANB3 SEPTIN6 MYO5C LONP1 SMC3 NAV3 HELZ RAB39B DNAH5 DNAH9 DYNC1H1 | 3.12e-06 | 848 | 159 | 22 | IPR027417 |
| Domain | Dynein_heavy_chain_D4_dom | 4.74e-06 | 14 | 159 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.74e-06 | 14 | 159 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.74e-06 | 14 | 159 | 4 | IPR013602 | |
| Domain | DHC_N2 | 4.74e-06 | 14 | 159 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.74e-06 | 14 | 159 | 4 | IPR011704 | |
| Domain | MT | 4.74e-06 | 14 | 159 | 4 | PF12777 | |
| Domain | AAA_8 | 4.74e-06 | 14 | 159 | 4 | PF12780 | |
| Domain | AAA_5 | 4.74e-06 | 14 | 159 | 4 | PF07728 | |
| Domain | - | DDX19B DNAH3 PNKP ERCC6L MYO7A SMC1A MCM6 ZNFX1 GIMAP7 RFC3 ZRANB3 SEPTIN6 LONP1 SMC3 NAV3 HELZ RAB39B DNAH5 DNAH9 DYNC1H1 | 5.63e-06 | 746 | 159 | 20 | 3.40.50.300 |
| Domain | DHC_fam | 6.42e-06 | 15 | 159 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 6.42e-06 | 15 | 159 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.42e-06 | 15 | 159 | 4 | IPR004273 | |
| Domain | Intermediate_filament_CS | 1.58e-05 | 63 | 159 | 6 | IPR018039 | |
| Domain | Filament | 3.14e-05 | 71 | 159 | 6 | SM01391 | |
| Domain | DHC_N1 | 3.29e-05 | 8 | 159 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.29e-05 | 8 | 159 | 3 | IPR013594 | |
| Domain | IF | 3.40e-05 | 72 | 159 | 6 | PS00226 | |
| Domain | Filament | 3.68e-05 | 73 | 159 | 6 | PF00038 | |
| Domain | IF | 4.63e-05 | 76 | 159 | 6 | IPR001664 | |
| Domain | Chromo_dom_subgr | 6.95e-05 | 10 | 159 | 3 | IPR017984 | |
| Domain | Lamin_B | 7.20e-05 | 2 | 159 | 2 | IPR027696 | |
| Domain | AAA | 2.35e-04 | 144 | 159 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 2.35e-04 | 144 | 159 | 7 | IPR003593 | |
| Domain | PINT | 3.13e-04 | 16 | 159 | 3 | SM00088 | |
| Domain | PCI_dom | 3.77e-04 | 17 | 159 | 3 | IPR000717 | |
| Domain | PCI | 3.77e-04 | 17 | 159 | 3 | PF01399 | |
| Domain | Chromodomain_CS | 4.50e-04 | 18 | 159 | 3 | IPR023779 | |
| Domain | Keratin_I | 5.27e-04 | 44 | 159 | 4 | IPR002957 | |
| Domain | SMC | 7.08e-04 | 5 | 159 | 2 | IPR024704 | |
| Domain | - | 7.08e-04 | 5 | 159 | 2 | 2.60.40.1260 | |
| Domain | Myosin_S1_N | 7.08e-04 | 5 | 159 | 2 | IPR008989 | |
| Domain | Lamin_tail_dom | 7.08e-04 | 5 | 159 | 2 | IPR001322 | |
| Domain | LTD | 7.08e-04 | 5 | 159 | 2 | PF00932 | |
| Domain | Dilute_dom | 1.06e-03 | 6 | 159 | 2 | IPR002710 | |
| Domain | SMC_hinge | 1.06e-03 | 6 | 159 | 2 | SM00968 | |
| Domain | DIL | 1.06e-03 | 6 | 159 | 2 | PF01843 | |
| Domain | SMC_hinge | 1.06e-03 | 6 | 159 | 2 | PF06470 | |
| Domain | DILUTE | 1.06e-03 | 6 | 159 | 2 | PS51126 | |
| Domain | SMC_hinge | 1.06e-03 | 6 | 159 | 2 | IPR010935 | |
| Domain | DIL | 1.06e-03 | 6 | 159 | 2 | SM01132 | |
| Domain | Chromo_domain | 1.07e-03 | 24 | 159 | 3 | IPR023780 | |
| Domain | Chromo | 1.36e-03 | 26 | 159 | 3 | PF00385 | |
| Domain | S04_transporter_CS | 1.47e-03 | 7 | 159 | 2 | IPR018045 | |
| Domain | Plectin | 1.47e-03 | 7 | 159 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.47e-03 | 7 | 159 | 2 | IPR001101 | |
| Domain | PLEC | 1.47e-03 | 7 | 159 | 2 | SM00250 | |
| Domain | CHROMO_1 | 1.70e-03 | 28 | 159 | 3 | PS00598 | |
| Domain | CHROMO_2 | 1.70e-03 | 28 | 159 | 3 | PS50013 | |
| Domain | Spectrin_repeat | 1.88e-03 | 29 | 159 | 3 | IPR002017 | |
| Domain | RecF/RecN/SMC_N | 1.95e-03 | 8 | 159 | 2 | IPR003395 | |
| Domain | SMC_N | 1.95e-03 | 8 | 159 | 2 | PF02463 | |
| Domain | SPEC | 2.51e-03 | 32 | 159 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.51e-03 | 32 | 159 | 3 | IPR018159 | |
| Domain | Chromodomain-like | 2.51e-03 | 32 | 159 | 3 | IPR016197 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL5A2 VLDLR KRT12 ANK1 MYO5A DSP KRT35 MYOD1 SPTBN1 PPL PIK3CA PLXNC1 CSNK2A1 KRT20 KRT36 EPHA4 | 1.51e-05 | 502 | 130 | 16 | MM14537 |
| Pubmed | TPM4 DNAH3 MYO5A MYO7A DSP SMC1A RPS9 MCM6 PSMD12 LMNB2 VPS26A ARID1A NSUN2 SEPTIN6 GMPS EEF1G LMNB1 SMC3 CBX1 PYGB PRPF19 EIF3C DYNC1H1 RPL11 | 6.14e-13 | 803 | 163 | 24 | 36517590 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HEXA TPM4 CUL3 DDX19B OGT SMC1A SPTBN1 RPS9 TOM1 CBX3 MCM6 PSMD12 VPS26A RFC3 COPS2 NSUN2 PPP4R3A GMPS EEF1G LMNB1 RABEP1 CSNK2A1 PHACTR4 BUB1B PYGB PRPF19 EIF3C UBE3C FERMT2 DYNC1H1 RPL11 | 1.42e-12 | 1455 | 163 | 31 | 22863883 |
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | OGT SMC1A CBX3 RFC3 ARID1A HIRA LMNB1 SMC3 CBX5 CBX1 PRPF19 RPL11 | 2.10e-12 | 135 | 163 | 12 | 31077711 |
| Pubmed | TPM4 NEMP1 OGT ACACB OFD1 MYO5A MYOD1 SMC1A SPTBN1 PSMD12 ARID1A NSUN2 DPM1 ZCCHC3 SEPTIN6 HEXIM2 HIRA MYO5C FHAD1 LONP1 SMC3 CSNK2A1 CBX1 HELZ PRPF19 ELF5 EIF3C SRRM2 DYNC1H1 HOMEZ | 4.98e-12 | 1429 | 163 | 30 | 35140242 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | OGT ANK1 ACACB SMC1A RPS9 CBX3 MCM6 PSMD12 VPS26A NSUN2 DPM1 ITIH4 ZCCHC3 GMPS LONP1 EEF1G LMNB1 SMC3 CBX5 CSNK2A1 PKLR CBX1 HELZ PRPF19 SRRM2 DYNC1H1 RPL11 | 1.15e-10 | 1318 | 163 | 27 | 30463901 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DSP POLE SMC1A SPTBN1 RPS9 CBX3 MCM6 PSMD12 LMNB2 RFC3 NSUN2 DPM1 LONP1 EEF1G LMNB1 SMC3 CSNK2A1 CD47 RBM15B PRPF19 PRKCI EIF3C UBE3C PEAK1 SRRM2 DNAH5 DYNC1H1 RPL11 | 1.29e-10 | 1425 | 163 | 28 | 30948266 |
| Pubmed | ABR ERCC6L DSP SMC1A SPTBN1 RPS9 CBX3 PSMD12 DPM1 GMPS EEF1G LMNB1 SMC3 PHACTR4 BUB1B PEAK1 FERMT2 USP6NL DYNC1H1 RPL11 | 1.62e-10 | 708 | 163 | 20 | 39231216 | |
| Pubmed | DDX19B PNKP OGT PPFIBP2 SMC1A SPTBN1 RPS9 CBX3 MCM6 PSMD12 RFC3 ARID1A NSUN2 DPM1 HEXIM2 GMPS LONP1 EEF1G LMNB1 SMC3 PIK3CA CBX5 PRPF19 SRRM2 DYNC1H1 RPL11 | 1.82e-10 | 1247 | 163 | 26 | 27684187 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A DSP POLE SMC1A SPTBN1 RPS9 CBX3 MCM6 LMNB2 VPS26A RFC3 ARID1A NSUN2 DPM1 HIRA GMPS LONP1 EEF1G LMNB1 SMC3 CBX1 PYGB PRPF19 FERMT2 SRRM2 DYNC1H1 RPL11 | 2.05e-10 | 1353 | 163 | 27 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | OFD1 MYO5A DSP SMC1A RPS9 CBX3 MCM6 LMNB2 RFC3 NSUN2 MYO5C LONP1 EEF1G LMNB1 SMC3 CBX5 CSNK2A1 CBX1 PRPF19 EIF3C SRRM2 DYNC1H1 RPL11 | 5.54e-10 | 1024 | 163 | 23 | 24711643 |
| Pubmed | TPM4 MYO5A DSP SPTBN1 RPS9 TOM1 CBX3 PSMD12 LMNB2 GMPS CBX5 EIF3C DYNC1H1 RPL11 | 7.21e-10 | 334 | 163 | 14 | 30425250 | |
| Pubmed | COL5A2 OGT MYO5A DSP SMC1A CBX3 MCM6 PSMD12 RFC3 NSUN2 GMPS SMC3 PRPF19 FERMT2 DYNC1H1 | 7.76e-10 | 399 | 163 | 15 | 37536630 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM4 CUL3 RBMXL1 MYO5A DSP SMC1A SPTBN1 RPS9 CBX3 LMNB2 RFC3 NSUN2 DPM1 ZCCHC3 PPL EEF1G KIN LMNB1 SMC3 CSNK2A1 RBM15B CBX1 PRPF19 DYNC1H1 RPL11 | 1.12e-09 | 1257 | 163 | 25 | 36526897 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TPM4 OGT RBMXL1 DSP SMC1A SPTBN1 RPS9 CBX3 LMNB2 ARID1A HIRA EEF1G KIN LMNB1 CBX5 CSNK2A1 RBM15B CBX1 PRPF19 EIF3C SRRM2 DYNC1H1 RPL11 | 1.59e-09 | 1082 | 163 | 23 | 38697112 |
| Pubmed | MYO5A DSP POLE SPTBN1 CBX3 MCM6 PSMD12 LMNB2 ARID1A NSUN2 ZCCHC3 GMPS LONP1 CSNK2A1 PYGB HELZ SRRM2 DYNC1H1 | 2.07e-09 | 653 | 163 | 18 | 22586326 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | DSP POLE SMC1A SPTBN1 RPS9 CBX3 LMNB2 RFC3 DPM1 GMPS EEF1G LMNB1 SMC3 CBX5 CSNK2A1 PRPF19 EIF3C | 2.59e-09 | 583 | 163 | 17 | 29844126 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM4 RBMXL1 MYO5A DSP SMC1A SPTBN1 RPS9 MCM6 DAXX NSUN2 DPM1 MYO5C EEF1G LMNB1 SMC3 PRPF19 EIF3C SRRM2 USP6NL DYNC1H1 RPL11 | 4.32e-09 | 949 | 163 | 21 | 36574265 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | DSP SMC1A SPTBN1 RPS9 CBX3 MCM6 RFC3 ARID1A LMNB1 SMC3 CBX5 RBM15B CBX1 PRPF19 EIF3C SRRM2 RPL11 | 4.49e-09 | 605 | 163 | 17 | 28977666 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CUL3 DDX19B OGT RBMXL1 DSP POLE SMC1A RPS9 TOM1 MCM6 PSMD12 RFC3 NSUN2 DPM1 GMPS EEF1G LMNB1 SMC3 PYGB PRPF19 EIF3C UBE3C DYNC1H1 RPL11 | 5.49e-09 | 1257 | 163 | 24 | 37317656 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CUL3 DDX19B OGT KRT35 SMC1A CBX3 MCM6 PSMD12 FBXO17 RFC3 COPS2 GMPS LONP1 SMC3 CSNK2A1 PKLR CBX1 PRKCI EIF3C SRRM2 KRT36 | 1.17e-08 | 1005 | 163 | 21 | 19615732 |
| Pubmed | PNKP SMC1A RPS9 CBX3 MCM6 RFC3 EEF1G KIN LMNB1 SMC3 CBX5 CBX1 PRPF19 DYNC1H1 | 1.30e-08 | 419 | 163 | 14 | 15635413 | |
| Pubmed | TPM4 ACACB MYO5A DSP RPS9 DAXX GMPS EEF1G PRPF19 SRRM2 DNAH5 | 1.58e-08 | 234 | 163 | 11 | 36243803 | |
| Pubmed | 1.61e-08 | 7 | 163 | 4 | 22615490 | ||
| Pubmed | KRT12 PNKP MYO5A SPTBN1 CBX3 LMNB2 NSUN2 LMNB1 SMC3 CBX5 CSNK2A1 CBX1 PRPF19 EIF3C SRRM2 USP6NL SH3BGRL3 | 1.61e-08 | 660 | 163 | 17 | 32780723 | |
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 1.66e-08 | 182 | 163 | 10 | 26527279 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM4 CUL3 OGT MYO5A DSP SMC1A SPTBN1 RPS9 TOM1 CBX3 MCM6 PSMD12 COPS2 NSUN2 GMPS EEF1G SMC3 CSNK2A1 PRPF19 SRRM2 DYNC1H1 RPL11 | 2.41e-08 | 1149 | 163 | 22 | 35446349 |
| Pubmed | DSP SMC1A RPS9 CBX3 MCM6 LMNB2 NSUN2 GMPS EEF1G LMNB1 CBX5 CSNK2A1 EIF3C RPL11 | 2.46e-08 | 441 | 163 | 14 | 31239290 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | SMC1A SPTBN1 CBX3 MCM6 PSMD12 LMNB2 NSUN2 PPL GMPS LONP1 LMNB1 CSNK2A1 PYGB PRPF19 EIF3C SRRM2 | 3.17e-08 | 607 | 163 | 16 | 39147351 |
| Pubmed | HEXA CUL3 DDX19B PNKP ABR OFD1 MYO5A ERCC6L RPS9 PSMD12 DPM1 LONP1 EEF1G LMNB1 PLXNC1 PYGB HELZ PRPF19 ETNK1 PLD1 DYNC1H1 RPL11 | 3.22e-08 | 1168 | 163 | 22 | 19946888 | |
| Pubmed | 3.51e-08 | 197 | 163 | 10 | 31620119 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DOCK4 DDX19B PNKP OGT ERCC6L DSP KRT35 POLE SMC1A RPS9 PSMD12 COPS2 DPM1 SEPTIN6 PPP4R3A TIAM1 SMC3 RABEP1 CSNK2A1 PRPF19 SRRM2 KRT36 DYNC1H1 | 3.80e-08 | 1284 | 163 | 23 | 17353931 |
| Pubmed | RBMXL1 DSP SPTBN1 CBX3 ZNFX1 PSMD12 LMNB2 RFC3 NSUN2 ZCCHC3 LONP1 EEF1G LMNB1 CSNK2A1 PRPF19 EIF3C DYNC1H1 | 4.73e-08 | 711 | 163 | 17 | 33022573 | |
| Pubmed | ERCC6L SMC1A SPTBN1 RPS9 MCM6 PSMD12 LMNB2 PPP4R3A GMPS LONP1 LMNB1 SMC3 PRPF19 EIF3C UBE3C DYNC1H1 | 6.28e-08 | 638 | 163 | 16 | 33239621 | |
| Pubmed | TPM4 CUL3 OGT MYO5A MYO7A DSP SPTBN1 RPS9 TOM1 ZNFX1 NDUFA2 ARID1A SEPTIN6 LONP1 EEF1G CSNK2A1 PDE4DIP PYGB PRPF19 EIF3C PEAK1 FERMT2 DYNC1H1 RPL11 | 6.37e-08 | 1431 | 163 | 24 | 37142655 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | DSP SMC1A SPTBN1 RPS9 MCM6 LMNB2 GMPS EEF1G LMNB1 SMC3 EIF3C SRRM2 DYNC1H1 RPL11 | 6.48e-08 | 477 | 163 | 14 | 31300519 |
| Pubmed | CUL3 PNKP OGT POLE SMC1A CBX3 MCM6 LMNB2 RFC3 COPS2 NSUN2 PPP4R3A GMPS BROX LONP1 EEF1G SMC3 CBX5 CSNK2A1 PYGB | 6.85e-08 | 1014 | 163 | 20 | 32416067 | |
| Pubmed | RBMXL1 MYO5A DSP SMC1A SPTBN1 RPS9 LMNB2 DPM1 ZCCHC3 LMNB1 SMC3 CSNK2A1 RBM15B PRPF19 EIF3C SRRM2 RPL11 | 7.03e-08 | 731 | 163 | 17 | 29298432 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | NEMP1 DNAH3 ANK1 MYO7A DSP RPS9 LMNB2 GIMAP7 GMPS EEF1G LMNB1 KRT20 CEP295 ALOX5 BANK1 DYNC1H1 RPL11 | 7.75e-08 | 736 | 163 | 17 | 29676528 |
| Pubmed | RBMXL1 DSP SMC1A SPTBN1 RPS9 CBX3 LMNB2 RFC3 PPL EEF1G LMNB1 SMC3 CBX1 PRPF19 SRRM2 RPL11 | 8.44e-08 | 652 | 163 | 16 | 31180492 | |
| Pubmed | TPM4 CUL3 FRAS1 TENT4A SMC1A MCM6 DAXX RFC3 DPM1 EEF1G SMC3 PRPF19 ELF5 EIF3C UBE3C SRRM2 | 8.61e-08 | 653 | 163 | 16 | 33742100 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 9.50e-08 | 219 | 163 | 10 | 31353912 | |
| Pubmed | OLIG2 is an in vivo bookmarking transcription factor in the developing neural tube in mouse. | 9.55e-08 | 10 | 163 | 4 | 36547371 | |
| Pubmed | Maintenance of stable heterochromatin domains by dynamic HP1 binding. | 1.01e-07 | 3 | 163 | 3 | 12560555 | |
| Pubmed | Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells. | 1.01e-07 | 3 | 163 | 3 | 10460410 | |
| Pubmed | Stage-specific expression of polycomb group genes in human bone marrow cells. | 1.01e-07 | 3 | 163 | 3 | 9454751 | |
| Pubmed | Dynamic associations of heterochromatin protein 1 with the nuclear envelope. | 1.01e-07 | 3 | 163 | 3 | 11101528 | |
| Pubmed | Gene regulation by human orthologs of Drosophila heterochromatin protein 1. | 1.01e-07 | 3 | 163 | 3 | 12054505 | |
| Pubmed | HP1gamma function is required for male germ cell survival and spermatogenesis. | 1.01e-07 | 3 | 163 | 3 | 20423503 | |
| Pubmed | Differential contribution of HP1 proteins to DNA end resection and homology-directed repair. | 1.01e-07 | 3 | 163 | 3 | 23287531 | |
| Pubmed | Pericentromeric heterochromatin domains are maintained without accumulation of HP1. | 1.01e-07 | 3 | 163 | 3 | 17314413 | |
| Pubmed | HP1 proteins compact DNA into mechanically and positionally stable phase separated domains. | 1.01e-07 | 3 | 163 | 3 | 33661100 | |
| Pubmed | N-terminal phosphorylation of HP1{alpha} promotes its chromatin binding. | 1.01e-07 | 3 | 163 | 3 | 21245376 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 17855382 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ACACB MYO5A SMC1A MCM6 PSMD12 ARID1A COPS2 GMPS LONP1 LMNB1 CSNK2A1 PRPF19 EIF3C SRRM2 DYNC1H1 RPL11 | 1.10e-07 | 665 | 163 | 16 | 30457570 |
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 1.14e-07 | 49 | 163 | 6 | 27352031 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX19B ERCC6L DSP POLE SMC1A SPTBN1 PSMD12 RFC3 ARID1A GMPS SMC3 BUB1B PRPF19 SRRM2 DYNC1H1 | 1.17e-07 | 582 | 163 | 15 | 20467437 |
| Pubmed | RBMXL1 DSP KRT35 SMC1A RPS9 PSMD12 RFC3 ZCCHC3 HEXIM2 EEF1G USF3 SMC3 CBX5 CSNK2A1 KRT20 PRPF19 EIF3C RAB39B KRT36 DYNC1H1 RPL11 | 1.19e-07 | 1153 | 163 | 21 | 29845934 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MYO7A SMC1A TOM1 SMC3 CSNK2A1 NBPF10 HELZ PRPF19 PLD1 SRRM2 DYNC1H1 EPHA4 | 1.42e-07 | 358 | 163 | 12 | 32460013 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CUL3 ERCC6L DSP SMC1A SPTBN1 DAXX NSUN2 PPL HEXIM2 PPP4R3A CSNK2A1 PHACTR4 RBM15B HELZ EIF3C SRRM2 HOMEZ | 1.58e-07 | 774 | 163 | 17 | 15302935 |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.97e-07 | 180 | 163 | 9 | 30110629 | |
| Pubmed | TPM4 MYO5A DSP SPTBN1 MCM6 LMNB2 NSUN2 LONP1 PYGB DYNC1H1 RPL11 | 2.90e-07 | 312 | 163 | 11 | 37120454 | |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 3.55e-07 | 59 | 163 | 6 | 16083285 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 17381543 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 10330177 | ||
| Pubmed | The mouse HP1 proteins are essential for preventing liver tumorigenesis. | 4.03e-07 | 4 | 163 | 3 | 32020053 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 15342492 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 31961023 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 10747027 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 9636146 | ||
| Pubmed | E3 ubiquitin ligase HECW2 mediates the proteasomal degradation of HP1 isoforms. | 4.03e-07 | 4 | 163 | 3 | 30208514 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 11793364 | ||
| Pubmed | DOCK4 ACACB MYO5A DSP SPTBN1 ZNFX1 PSMD12 NDUFA2 SEPTIN6 GMPS LONP1 EEF1G RABEP1 PDE4DIP NAV3 PYGB HELZ EIF3C PEAK1 FERMT2 | 4.34e-07 | 1139 | 163 | 20 | 36417873 | |
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 20231385 | ||
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 21875947 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM4 ACACB ERCC6L DSP RPS9 CBX3 NSUN2 PPP4R3A GMPS EEF1G RABEP1 BUB1B CBX1 HELZ PRPF19 EIF3C FERMT2 RPL11 | 4.54e-07 | 934 | 163 | 18 | 33916271 |
| Pubmed | TPM4 COL5A2 MAN2A2 DSP KRT35 SPTBN1 CBX3 RFC3 NSUN2 ALKBH5 DPM1 SEPTIN6 HEXIM2 EEF1G LMNB1 CSNK2A1 RBM15B PRPF19 PRKCI PLD1 DYNC1H1 SH3BGRL3 | 5.02e-07 | 1371 | 163 | 22 | 36244648 | |
| Pubmed | TPM4 DSP SPTBN1 RPS9 NDUFA2 VPS26A LONP1 PYGB CPLANE1 DNAH5 DYNC1H1 | 5.21e-07 | 331 | 163 | 11 | 29199018 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 5.33e-07 | 264 | 163 | 10 | 32814769 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CUL3 OGT ERCC6L SMC1A TMEM63B CBX3 ARID1A COPS2 NSUN2 PPL NEK2 KIN LMNB1 SMC3 BUB1B CBX1 PRPF19 PRKCI EIF3C DYNC1H1 | 5.39e-07 | 1155 | 163 | 20 | 20360068 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM4 DNAH3 MYO7A DSP SMC1A SPTBN1 RPS9 MCM6 PSMD12 ARID1A SEPTIN6 PPP4R3A EEF1G SMC3 EIF3C DYNC1H1 RPL11 | 5.54e-07 | 847 | 163 | 17 | 35235311 |
| Pubmed | TPM4 DSP SPTBN1 CBX3 DAXX PPP4R3A USF3 SMC3 NAV3 KRT20 HELZ ATF4 CPLANE1 | 5.56e-07 | 486 | 163 | 13 | 20936779 | |
| Pubmed | OGT DSP SMC1A SPTBN1 RPS9 MCM6 PSMD12 GMPS EEF1G LMNB1 SMC3 PRPF19 RPL11 | 6.68e-07 | 494 | 163 | 13 | 26831064 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 DDX19B OFD1 ERCC6L DSP SPTBN1 CCDC18 MAP3K6 TIAM1 RABEP1 PHACTR4 BUB1B HELZ PRKCI PEAK1 SRRM2 USP6NL | 6.94e-07 | 861 | 163 | 17 | 36931259 |
| Pubmed | 6.99e-07 | 272 | 163 | 10 | 31010829 | ||
| Pubmed | CUL3 OGT ABR MYO5A SPTBN1 CBX3 ZNFX1 LMNB2 ITIH4 HIRA CCDC13 LMNB1 RABEP1 CSNK2A1 PDE4DIP PRKCI DYNC1H1 EPHA4 | 7.04e-07 | 963 | 163 | 18 | 28671696 | |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 23077635 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 10562550 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 11959914 | ||
| Pubmed | Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. | 1.00e-06 | 5 | 163 | 3 | 17962312 | |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 16127177 | ||
| Pubmed | Human inactive X chromosome is compacted through a PRC2-independent SMCHD1-HBiX1 pathway. | 1.00e-06 | 5 | 163 | 3 | 23542155 | |
| Pubmed | An HP1 isoform-specific feedback mechanism regulates Suv39h1 activity under stress conditions. | 1.00e-06 | 5 | 163 | 3 | 28059589 | |
| Pubmed | CUL3 DDX19B OGT SMC1A PSMD12 RFC3 ARID1A NSUN2 ALKBH5 SEPTIN6 PPP4R3A GMPS EEF1G SMC3 CSNK2A1 PRPF19 SRRM2 DYNC1H1 HOMEZ | 1.14e-06 | 1103 | 163 | 19 | 34189442 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DDX19B POLE CBX3 MCM6 PSMD12 RFC3 COPS2 DPM1 EEF1G SMC3 CBX5 PRKCI EIF3C DNAH5 DYNC1H1 | 1.28e-06 | 704 | 163 | 15 | 29955894 |
| Pubmed | CUL3 RPS9 CBX3 MCM6 PSMD12 LMNB2 RFC3 COPS2 NSUN2 ALKBH5 DPM1 GMPS LONP1 EEF1G LMNB1 SMC3 CSNK2A1 CBX1 PRPF19 EIF3C RPL11 | 1.28e-06 | 1335 | 163 | 21 | 29229926 | |
| Pubmed | 1.33e-06 | 116 | 163 | 7 | 21549307 | ||
| Pubmed | SPTBN1 RPS9 CBX3 MCM6 NDUFA2 VPS26A NSUN2 GMPS BROX EEF1G LMNB1 CSNK2A1 PRPF19 DYNC1H1 RPL11 | 1.35e-06 | 707 | 163 | 15 | 19738201 | |
| Pubmed | CUL3 DSP SMC1A SPTBN1 RPS9 RFC3 NSUN2 LONP1 EEF1G LMNB1 SMC3 PRPF19 EIF3C SRRM2 DYNC1H1 RPL11 | 1.47e-06 | 809 | 163 | 16 | 32129710 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.59e-06 | 231 | 163 | 9 | 16452087 | |
| Pubmed | TPM4 SMC1A SPTBN1 RPS9 PSMD12 COPS2 SEPTIN6 EEF1G SMC3 BUB1B EIF3C DYNC1H1 RPL11 | 1.72e-06 | 538 | 163 | 13 | 28524877 | |
| Interaction | TRIM24 interactions | TPM4 CUL3 RBMXL1 MYOD1 SMC1A SPTBN1 CBX3 E2F2 MCM6 LMNB1 SMC3 CBX5 CBX1 HELZ ELF5 ATF4 | 1.44e-07 | 398 | 162 | 16 | int:TRIM24 |
| Interaction | KCNA3 interactions | ABR ERCC6L DSP SMC1A SPTBN1 RPS9 CBX3 PSMD12 DPM1 PPL MYO5C GMPS EEF1G LMNB1 SMC3 PHACTR4 BUB1B PEAK1 FERMT2 DNAH5 USP6NL DYNC1H1 RPL11 | 5.16e-07 | 871 | 162 | 23 | int:KCNA3 |
| Interaction | USP7 interactions | TPM4 CUL3 OGT ANK1 ACACB OFD1 MYO5A ERCC6L DSP SPTBN1 MAFA BCHE MCM6 DAXX PPL GMPS NEK2 EEF1G LMNB1 CSNK2A1 KCNK3 MMRN2 PRPF19 PRKCI RAB39B MDGA1 SRRM2 DNAH5 DYNC1H1 | 6.05e-07 | 1313 | 162 | 29 | int:USP7 |
| Interaction | SOX2 interactions | OGT DSP PPFIBP2 SMC1A SPTBN1 TOM1 CBX3 PSMD12 LMNB2 RFC3 ARID1A DPM1 ITIH4 PPL CFB HIRA LONP1 EEF1G LMNB1 SMC3 CBX5 NAV3 CBX1 HELZ PRPF19 ATF4 CPLANE1 FERMT2 RPL11 HOMEZ | 9.77e-07 | 1422 | 162 | 30 | int:SOX2 |
| Interaction | DCTN2 interactions | TPM4 CUL3 OGT OFD1 MCM6 PSMD12 PPP4R3A MYO5C NPHS2 LMNB1 RABEP1 PDGFD PRKCI DYNC1H1 | 1.17e-06 | 356 | 162 | 14 | int:DCTN2 |
| Interaction | H4C6 interactions | 1.35e-06 | 69 | 162 | 7 | int:H4C6 | |
| Interaction | MOB3C interactions | COL5A2 OGT DSP SMC1A CBX3 MCM6 PSMD12 RFC3 NSUN2 GMPS SMC3 PRPF19 FERMT2 DYNC1H1 | 1.51e-06 | 364 | 162 | 14 | int:MOB3C |
| Interaction | USP14 interactions | TPM4 OGT MYO5A DSP SPTBN1 RPS9 TOM1 CBX3 PSMD12 LMNB2 GMPS CBX5 EIF3C IL6 DYNC1H1 RPL11 | 2.19e-06 | 489 | 162 | 16 | int:USP14 |
| Interaction | H3C6 interactions | 2.24e-06 | 226 | 162 | 11 | int:H3C6 | |
| Interaction | SNW1 interactions | CUL3 DDX19B OGT DSP MYOD1 POLE SMC1A SPTBN1 CBX3 DAXX PSMD12 RFC3 ARID1A EEF1G LMNB1 SMC3 RABEP1 BUB1B PRPF19 SRRM2 | 2.48e-06 | 747 | 162 | 20 | int:SNW1 |
| Interaction | ECT2 interactions | TPM4 COL5A2 ABR OFD1 RBMXL1 DSP SPTBN1 RPS9 MCM6 RFC3 ARID1A NSUN2 MYO5C EEF1G NAV3 PRPF19 UBE3C SRRM2 DNAH9 USP6NL DYNC1H1 RPL11 | 2.61e-06 | 887 | 162 | 22 | int:ECT2 |
| Interaction | AURKB interactions | ZNF438 TPM4 CUL3 OGT ABR OFD1 DSP SMC1A RPS9 CBX3 PSMD12 NSUN2 DPM1 LONP1 CBX5 BUB1B UBE3C SRRM2 DYNC1H1 RPL11 | 3.28e-06 | 761 | 162 | 20 | int:AURKB |
| Interaction | PRC1 interactions | OGT RBMXL1 DSP SPTBN1 RPS9 CBX3 MCM6 LMNB2 FAM200A ARID1A NSUN2 ITIH4 LONP1 EEF1G USF3 LMNB1 CBX5 CBX1 KRT20 PRPF19 SRRM2 DYNC1H1 RPL11 | 3.38e-06 | 973 | 162 | 23 | int:PRC1 |
| Interaction | KIF20A interactions | ZNF438 TPM4 CUL3 RBMXL1 DSP INPP5B SPTBN1 RPS9 CBX3 LMNB2 FAM200A NSUN2 ITIH4 PPL LONP1 EEF1G LMNB1 CBX5 RABEP1 NAV3 HELZ PRPF19 SRRM2 RPL11 | 3.72e-06 | 1052 | 162 | 24 | int:KIF20A |
| Interaction | H3-3B interactions | 3.92e-06 | 114 | 162 | 8 | int:H3-3B | |
| Interaction | RHOH interactions | TPM4 MYO5A SPTBN1 MCM6 PSMD12 LMNB2 DPM1 LONP1 LMNB1 PIK3CA KCNH2 PHACTR4 PRKCI PEAK1 FERMT2 USP6NL | 3.94e-06 | 512 | 162 | 16 | int:RHOH |
| Interaction | CUL7 interactions | TPM4 CUL3 FAM184A DSP SMC1A RPS9 CBX3 LMNB2 SEPTIN6 LONP1 EEF1G LMNB1 SMC3 CBX5 CSNK2A1 RBM15B CBX1 PRPF19 SRRM2 DYNC1H1 RPL11 | 4.37e-06 | 845 | 162 | 21 | int:CUL7 |
| Interaction | AR interactions | TPM4 OGT MYO5A DSP SMC1A RPS9 TOM1 DAXX PSMD12 ARID1A COPS2 NSUN2 HIRA MYO5C GMPS RNASEL LMNB1 SMC3 CBX5 CSNK2A1 CBX1 PRPF19 DYNC1H1 | 4.65e-06 | 992 | 162 | 23 | int:AR |
| Interaction | MKI67 interactions | CUL3 DNAH3 FRAS1 OGT RBMXL1 SMC1A CBX3 MCM6 DAXX LMNB2 HIRA LONP1 SMC3 CBX5 BUB1B CBX1 ELF5 EIF3C | 4.95e-06 | 648 | 162 | 18 | int:MKI67 |
| Interaction | CDC5L interactions | CUL3 DDX19B OGT ERCC6L DSP SMC1A SPTBN1 PSMD12 RFC3 ARID1A COPS2 GMPS EEF1G SMC3 CSNK2A1 PDE4DIP BUB1B PRPF19 SRRM2 DYNC1H1 RPL11 | 5.24e-06 | 855 | 162 | 21 | int:CDC5L |
| Interaction | CHMP4B interactions | COL5A2 OFD1 RBMXL1 DSP SPTBN1 RPS9 TMEM63B DAXX VPS26A RFC3 NSUN2 BROX LONP1 EEF1G LMNB1 SMC3 CBX1 SRRM2 RPL11 | 6.37e-06 | 727 | 162 | 19 | int:CHMP4B |
| Interaction | EP300 interactions | TPM4 CUL3 FRAS1 ANK1 TENT4A MYOD1 SMC1A CBX3 MCM6 DAXX RFC3 ARID1A COPS2 DPM1 SEPTIN6 HIRA GMPS EEF1G SMC3 CBX5 CSNK2A1 CBX1 PRPF19 ELF5 ATF4 EIF3C UBE3C SRRM2 | 6.69e-06 | 1401 | 162 | 28 | int:EP300 |
| Interaction | NR2C2 interactions | OGT ANK1 ACACB SMC1A RPS9 CBX3 MCM6 PSMD12 VPS26A NSUN2 DPM1 ITIH4 ZCCHC3 HIRA GMPS LONP1 EEF1G LMNB1 SMC3 CBX5 CSNK2A1 PKLR CBX1 HELZ PRPF19 SRRM2 DYNC1H1 RPL11 | 6.87e-06 | 1403 | 162 | 28 | int:NR2C2 |
| Interaction | ZC3H18 interactions | CUL3 RBMXL1 MYO5A DSP SMC1A SPTBN1 RPS9 DAXX LMNB2 DPM1 ZCCHC3 LMNB1 SMC3 CSNK2A1 RBM15B PRPF19 ELF5 EIF3C PLD1 SRRM2 RPL11 | 7.73e-06 | 877 | 162 | 21 | int:ZC3H18 |
| Interaction | WDR5 interactions | CUL3 OGT ACACB RBMXL1 DSP SPTBN1 MAFA CBX3 ZNFX1 PSMD12 LMNB2 RFC3 NSUN2 ZCCHC3 LONP1 EEF1G LMNB1 PIK3CA CSNK2A1 CBX1 PRPF19 ELF5 EIF3C DYNC1H1 | 8.03e-06 | 1101 | 162 | 24 | int:WDR5 |
| Interaction | YWHAH interactions | CUL3 DOCK4 OGT OFD1 ERCC6L DSP PPFIBP2 SPTBN1 CCDC18 MAP3K6 TIAM1 PIK3CA KCNH2 RABEP1 PHACTR4 KCNK3 RBM15B PRKCI PEAK1 FERMT2 SRRM2 USP6NL FRMD5 HOMEZ | 8.16e-06 | 1102 | 162 | 24 | int:YWHAH |
| Interaction | NUPR1 interactions | KRT12 PNKP MYO5A MYOD1 SPTBN1 CBX3 LMNB2 NSUN2 LMNB1 SMC3 CBX5 CSNK2A1 CBX1 PRPF19 EIF3C SRRM2 USP6NL SH3BGRL3 | 1.01e-05 | 683 | 162 | 18 | int:NUPR1 |
| Interaction | MIS18BP1 interactions | 1.25e-05 | 64 | 162 | 6 | int:MIS18BP1 | |
| Interaction | CIT interactions | TPM4 CUL3 PNKP RBMXL1 DSP SMC1A SPTBN1 RPS9 CBX3 LMNB2 FAM200A RFC3 NSUN2 DPM1 ITIH4 LONP1 EEF1G LMNB1 SMC3 CBX5 CSNK2A1 CBX1 PRPF19 FERMT2 SRRM2 DYNC1H1 FRMD5 RPL11 | 1.27e-05 | 1450 | 162 | 28 | int:CIT |
| Interaction | KRT8 interactions | CUL3 DOCK4 KRT12 OGT OFD1 DSP KRT35 CCDC18 PPL RABEP1 BUB1B KRT20 HELZ KRT36 | 1.37e-05 | 441 | 162 | 14 | int:KRT8 |
| Interaction | RBBP7 interactions | CUL3 OGT ACACB SMC1A DAXX ARID1A COPS2 PPL PPP4R3A HIRA EEF1G SMC3 CBX5 CSNK2A1 RPL11 | 1.53e-05 | 507 | 162 | 15 | int:RBBP7 |
| Interaction | ANKRD55 interactions | 1.63e-05 | 228 | 162 | 10 | int:ANKRD55 | |
| Interaction | YWHAG interactions | CUL3 DOCK4 DDX19B OGT ERCC6L DSP PPFIBP2 SPTBN1 CCDC18 MAP3K6 EEF1G TIAM1 RABEP1 PHACTR4 KCNK3 RBM15B HELZ PRPF19 PRKCI PEAK1 SRRM2 USP6NL DYNC1H1 FRMD5 HOMEZ | 2.15e-05 | 1248 | 162 | 25 | int:YWHAG |
| Interaction | EHMT1 interactions | 2.19e-05 | 188 | 162 | 9 | int:EHMT1 | |
| Interaction | ZNF829 interactions | 2.63e-05 | 22 | 162 | 4 | int:ZNF829 | |
| Interaction | GTF3C4 interactions | 2.92e-05 | 195 | 162 | 9 | int:GTF3C4 | |
| Interaction | COPS9 interactions | 2.97e-05 | 45 | 162 | 5 | int:COPS9 | |
| Interaction | ACTR10 interactions | 3.03e-05 | 110 | 162 | 7 | int:ACTR10 | |
| Interaction | CIC interactions | DSP POLE SMC1A SPTBN1 RPS9 CBX3 LMNB2 RFC3 DPM1 GMPS EEF1G LMNB1 SMC3 CBX5 CSNK2A1 PRPF19 EIF3C | 3.10e-05 | 673 | 162 | 17 | int:CIC |
| Interaction | SIRT7 interactions | MYO5A DSP POLE SPTBN1 CBX3 MCM6 PSMD12 LMNB2 ARID1A NSUN2 ZCCHC3 GMPS LONP1 CSNK2A1 PYGB HELZ SRRM2 DYNC1H1 | 3.16e-05 | 744 | 162 | 18 | int:SIRT7 |
| Interaction | EED interactions | TPM4 CUL3 PNKP OGT ACACB DSP SMC1A SPTBN1 RPS9 TOM1 CBX3 MCM6 PSMD12 LMNB2 ARID1A NSUN2 GMPS EEF1G LMNB1 SMC3 PRPF19 UBE3C MDGA1 FERMT2 SRRM2 DYNC1H1 RPL11 | 3.30e-05 | 1445 | 162 | 27 | int:EED |
| Interaction | KPNA3 interactions | 3.35e-05 | 248 | 162 | 10 | int:KPNA3 | |
| Interaction | HSF1 interactions | DSP SMC1A RPS9 MCM6 DAXX PSMD12 VPS26A RFC3 NSUN2 DPM1 ITIH4 GMPS EEF1G CSNK2A1 HELZ CPLANE1 | 3.36e-05 | 609 | 162 | 16 | int:HSF1 |
| Interaction | RNF123 interactions | CUL3 NEMP1 DNAH3 ANK1 MYO7A DSP RPS9 LMNB2 GIMAP7 MAP3K6 GMPS EEF1G LMNB1 KRT20 CEP295 ALOX5 BANK1 DYNC1H1 RPL11 | 3.63e-05 | 824 | 162 | 19 | int:RNF123 |
| Interaction | OBSL1 interactions | DSP SMC1A RPS9 CBX3 MCM6 DAXX RSPH6A PSMD12 LMNB2 PPP4R3A EEF1G LMNB1 SMC3 CBX5 CSNK2A1 CBX1 PRPF19 SRRM2 DYNC1H1 RPL11 | 3.87e-05 | 902 | 162 | 20 | int:OBSL1 |
| Interaction | NSD3 interactions | 4.50e-05 | 117 | 162 | 7 | int:NSD3 | |
| Interaction | NASP interactions | 4.66e-05 | 207 | 162 | 9 | int:NASP | |
| Interaction | BAP1 interactions | TPM4 CUL3 OGT MYO5A DSP MYOD1 SMC1A SPTBN1 RPS9 TOM1 CBX3 MCM6 PSMD12 COPS2 NSUN2 GMPS EEF1G SMC3 CBX5 CSNK2A1 CBX1 PRPF19 SRRM2 DYNC1H1 RPL11 | 5.02e-05 | 1314 | 162 | 25 | int:BAP1 |
| Interaction | ZNF558 interactions | 5.24e-05 | 26 | 162 | 4 | int:ZNF558 | |
| Interaction | C9orf72 interactions | CUL3 DDX19B OGT RBMXL1 DSP POLE SMC1A RPS9 TOM1 MCM6 PSMD12 RFC3 NSUN2 DPM1 GMPS EEF1G LMNB1 SMC3 PYGB PRPF19 EIF3C UBE3C RAB39B DYNC1H1 RPL11 | 5.34e-05 | 1319 | 162 | 25 | int:C9orf72 |
| Interaction | CDK2 interactions | TPM4 OGT OFD1 MYO5A DSP MYOD1 SMC1A SPTBN1 RPS9 MCM6 HIRA EEF1G SMC3 CSNK2A1 EIF3C SRRM2 DYNC1H1 RPL11 | 6.12e-05 | 783 | 162 | 18 | int:CDK2 |
| Interaction | WDR76 interactions | CUL3 FRAS1 DSP SMC1A SPTBN1 CBX3 LONP1 LMNB1 SMC3 CBX5 CBX1 SRRM2 | 6.51e-05 | 383 | 162 | 12 | int:WDR76 |
| Interaction | CHD4 interactions | CUL3 DSP SMC1A RPS9 CBX3 MCM6 DAXX ARID1A PPP4R3A LMNB1 SMC3 CBX5 CSNK2A1 RBM15B CBX1 PRPF19 PRKCI EIF3C SRRM2 RPL11 | 6.66e-05 | 938 | 162 | 20 | int:CHD4 |
| Interaction | H2BC9 interactions | FRAS1 ERCC6L DSP PPFIBP2 SMC1A MAFA MCM6 FHAD1 EEF1G USF3 SMC3 PDE4DIP DNAH5 | 6.71e-05 | 446 | 162 | 13 | int:H2BC9 |
| Interaction | KDM1A interactions | CUL3 PNKP OGT ACACB OFD1 DSP KRT35 MYOD1 CBX3 COPS2 SEPTIN6 GREB1L RABEP1 CSNK2A1 PDE4DIP BUB1B CBX1 ELF5 UBE3C HOMEZ | 6.96e-05 | 941 | 162 | 20 | int:KDM1A |
| Interaction | NUCKS1 interactions | 7.46e-05 | 220 | 162 | 9 | int:NUCKS1 | |
| Interaction | RND3 interactions | TPM4 MYO5A DSP SPTBN1 LONP1 PHACTR4 PRKCI PEAK1 FERMT2 USP6NL | 7.49e-05 | 273 | 162 | 10 | int:RND3 |
| Interaction | HNRNPCL2 interactions | RBMXL1 ERCC6L MAP3K6 ZCCHC3 BROX RNASEL KIN PHACTR4 PRKCI PLCB2 | 7.73e-05 | 274 | 162 | 10 | int:HNRNPCL2 |
| Interaction | ACE2 interactions | TPM4 DSP SMC1A SPTBN1 RPS9 MCM6 PSMD12 NDUFA2 NSUN2 DPM1 GMPS LONP1 EEF1G LMNB1 CBX5 RABEP1 PRPF19 EIF3C SRRM2 DYNC1H1 SH3BGRL3 RPL11 | 7.84e-05 | 1106 | 162 | 22 | int:ACE2 |
| Interaction | BTF3 interactions | TPM4 CUL3 PDE6C MYO5A DSP SPTBN1 RPS9 PSMD12 NDUFA2 RFC3 HIRA LONP1 EEF1G LMNB1 EIF3C SRRM2 DYNC1H1 RPL11 | 7.92e-05 | 799 | 162 | 18 | int:BTF3 |
| Interaction | KPNA2 interactions | CUL3 NEMP1 OGT MCM6 DPM1 PPP4R3A LMNB1 CBX5 CBX1 PRPF19 PRKCI ELF5 RAB39B HOMEZ | 8.04e-05 | 519 | 162 | 14 | int:KPNA2 |
| Interaction | CCDC8 interactions | OFD1 MYO5A DSP SMC1A MCM6 LMNB2 RFC3 NSUN2 MYO5C EEF1G LMNB1 SMC3 CSNK2A1 EIF3C DYNC1H1 RPL11 | 8.10e-05 | 656 | 162 | 16 | int:CCDC8 |
| Interaction | KPNA6 interactions | 8.40e-05 | 174 | 162 | 8 | int:KPNA6 | |
| Interaction | PXN interactions | CUL3 DOCK4 NEMP1 OFD1 CCDC18 DPM1 LONP1 PKLR HELZ PEAK1 FERMT2 | 8.50e-05 | 334 | 162 | 11 | int:PXN |
| Interaction | PIH1D1 interactions | TPM4 OGT OFD1 DSP SMC1A SPTBN1 RPS9 CBX3 NSUN2 GMPS LONP1 EEF1G CSNK2A1 EIF3C SRRM2 DYNC1H1 RPL11 | 8.61e-05 | 731 | 162 | 17 | int:PIH1D1 |
| Interaction | GRB2 interactions | CUL3 DOCK4 KRT35 SPTBN1 E2F2 COPS2 ITIH4 EEF1G PIK3CA PHACTR4 HELZ PEAK1 ALOX5 USP6NL KRT36 DYNC1H1 HOMEZ EPHA4 | 8.85e-05 | 806 | 162 | 18 | int:GRB2 |
| Interaction | KPNA4 interactions | 8.86e-05 | 225 | 162 | 9 | int:KPNA4 | |
| Interaction | LCK interactions | CUL3 RBMXL1 MYO5A DSP SPTBN1 RPS9 SOCS2 EEF1G PIK3CA PHACTR4 PEAK1 FERMT2 USP6NL | 9.77e-05 | 463 | 162 | 13 | int:LCK |
| Interaction | MECP2 interactions | TPM4 OGT RBMXL1 DSP SMC1A SPTBN1 RPS9 CBX3 LMNB2 ARID1A HIRA EEF1G KIN LMNB1 SMC3 CBX5 CSNK2A1 RBM15B CBX1 PRPF19 EIF3C SRRM2 DYNC1H1 RPL11 | 9.86e-05 | 1287 | 162 | 24 | int:MECP2 |
| Interaction | H4C13 interactions | 1.03e-04 | 58 | 162 | 5 | int:H4C13 | |
| Interaction | ZNF226 interactions | 1.06e-04 | 12 | 162 | 3 | int:ZNF226 | |
| Interaction | RHOF interactions | TPM4 DDX19B MYO5A SLC26A2 SPTBN1 LMNB2 NSUN2 DPM1 LONP1 LMNB1 TIAM1 PHACTR4 PRKCI PEAK1 FERMT2 USP6NL | 1.09e-04 | 673 | 162 | 16 | int:RHOF |
| Interaction | RBBP5 interactions | 1.13e-04 | 287 | 162 | 10 | int:RBBP5 | |
| Interaction | TNIP1 interactions | TPM4 PNKP OFD1 RBMXL1 MYO5A DSP SMC1A SPTBN1 RPS9 MCM6 DAXX NSUN2 DPM1 MYO5C EEF1G LMNB1 SMC3 PRPF19 EIF3C SRRM2 USP6NL DYNC1H1 RPL11 | 1.15e-04 | 1217 | 162 | 23 | int:TNIP1 |
| Interaction | MAU2 interactions | 1.17e-04 | 136 | 162 | 7 | int:MAU2 | |
| Interaction | ANAPC2 interactions | 1.19e-04 | 234 | 162 | 9 | int:ANAPC2 | |
| Interaction | KRT2 interactions | 1.27e-04 | 236 | 162 | 9 | int:KRT2 | |
| Interaction | ZNF280C interactions | 1.31e-04 | 61 | 162 | 5 | int:ZNF280C | |
| Interaction | AIRE interactions | 1.33e-04 | 97 | 162 | 6 | int:AIRE | |
| Interaction | KLHL4 interactions | 1.37e-04 | 33 | 162 | 4 | int:KLHL4 | |
| Interaction | ZFP82 interactions | 1.37e-04 | 13 | 162 | 3 | int:ZFP82 | |
| Interaction | ZFP30 interactions | 1.37e-04 | 13 | 162 | 3 | int:ZFP30 | |
| Interaction | SSB interactions | CUL3 OGT POLE TOM1 CBX3 NSUN2 LMNB1 SMC3 CSNK2A1 PRPF19 PRKCI EIF3C RPL11 | 1.52e-04 | 484 | 162 | 13 | int:SSB |
| Interaction | ALDH1B1 interactions | 1.54e-04 | 190 | 162 | 8 | int:ALDH1B1 | |
| Interaction | CEBPA interactions | CUL3 DDX19B OGT SMC1A SPTBN1 RPS9 PSMD12 RFC3 ARID1A NSUN2 ALKBH5 SEPTIN6 PPP4R3A GMPS EEF1G LMNB1 SMC3 CSNK2A1 PRPF19 ATF4 SRRM2 DYNC1H1 HOMEZ | 1.60e-04 | 1245 | 162 | 23 | int:CEBPA |
| Interaction | BDP1 interactions | 1.64e-04 | 64 | 162 | 5 | int:BDP1 | |
| Interaction | CALM1 interactions | TPM4 CUL3 MYO5A MYO7A MYOD1 TOM1 PSMD12 PIK3CA CSNK2A1 PHACTR4 PDE4DIP EIF3C UBE3C PEAK1 EPHA4 | 1.65e-04 | 626 | 162 | 15 | int:CALM1 |
| Interaction | BRCA1 interactions | DOCK4 FAM184A OGT DSP POLE SMC1A SPTBN1 RPS9 CBX3 MCM6 PSMD12 ARID1A GMPS EEF1G LMNB1 SMC3 CBX5 CSNK2A1 CBX1 PRPF19 UBE3C DYNC1H1 RPL11 | 1.68e-04 | 1249 | 162 | 23 | int:BRCA1 |
| Interaction | STIP1 interactions | OGT OFD1 ERCC6L SMC1A SPTBN1 RPS9 MCM6 PSMD12 LMNB2 PPP4R3A GMPS LONP1 LMNB1 SMC3 KCNH2 CSNK2A1 PRPF19 EIF3C UBE3C DYNC1H1 | 1.71e-04 | 1006 | 162 | 20 | int:STIP1 |
| Interaction | BUB1B interactions | 1.85e-04 | 195 | 162 | 8 | int:BUB1B | |
| Interaction | SMARCAD1 interactions | 1.98e-04 | 197 | 162 | 8 | int:SMARCAD1 | |
| Interaction | ZNF776 interactions | 2.16e-04 | 15 | 162 | 3 | int:ZNF776 | |
| Interaction | ZNF566 interactions | 2.16e-04 | 15 | 162 | 3 | int:ZNF566 | |
| Interaction | UBE2O interactions | PNKP RBMXL1 MYO5A DSP MYOD1 CBX3 MCM6 DAXX RFC3 ALKBH5 EEF1G CSNK2A1 PRPF19 PLD1 SRRM2 DYNC1H1 RPL11 | 2.17e-04 | 790 | 162 | 17 | int:UBE2O |
| Interaction | H3C2 interactions | 2.19e-04 | 68 | 162 | 5 | int:H3C2 | |
| Interaction | MST1R interactions | 2.19e-04 | 200 | 162 | 8 | int:MST1R | |
| Interaction | CEBPB interactions | TPM4 PNKP DSP SMC1A CCDC18 CBX3 MCM6 DAXX PSMD12 NDUFA2 RFC3 NSUN2 GMPS EEF1G LMNB1 SMC3 CBX5 CBX1 PRPF19 ATF4 EIF3C SRRM2 DYNC1H1 SH3BGRL3 RPL11 | 2.20e-04 | 1443 | 162 | 25 | int:CEBPB |
| Interaction | SNCA interactions | PNKP DSP SPTBN1 CBX3 DPM1 PPP4R3A GMPS CSNK2A1 PDE4DIP PRPF19 PLCB2 CEP295 PLD1 FERMT2 DYNC1H1 RPL11 | 2.20e-04 | 716 | 162 | 16 | int:SNCA |
| Interaction | NDC80 interactions | 2.23e-04 | 312 | 162 | 10 | int:NDC80 | |
| Interaction | RBBP4 interactions | CUL3 OGT ACACB DSP SMC1A CBX3 ARID1A COPS2 HIRA SMC3 CBX5 CSNK2A1 CBX1 SRRM2 | 2.25e-04 | 573 | 162 | 14 | int:RBBP4 |
| Cytoband | 3q26.3 | 1.24e-04 | 5 | 163 | 2 | 3q26.3 | |
| GeneFamily | Chromobox family | 1.17e-05 | 8 | 109 | 3 | 976 | |
| GeneFamily | Keratins, type I | 2.29e-05 | 28 | 109 | 4 | 608 | |
| GeneFamily | Myosins, class V | 1.08e-04 | 3 | 109 | 2 | 1100 | |
| GeneFamily | Lamins | 1.08e-04 | 3 | 109 | 2 | 612 | |
| GeneFamily | Dyneins, axonemal | 1.36e-04 | 17 | 109 | 3 | 536 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 7.42e-04 | 7 | 109 | 2 | 761 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.85e-04 | 8 | 109 | 2 | 939 | |
| GeneFamily | Cohesin complex | 9.85e-04 | 8 | 109 | 2 | 1060 | |
| GeneFamily | UPF1 like RNA helicases | 1.91e-03 | 11 | 109 | 2 | 1169 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 3.40e-03 | 50 | 109 | 3 | 1293 | |
| GeneFamily | Cadherin related | 4.62e-03 | 17 | 109 | 2 | 24 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | NEMP1 OGT POLE SMC1A CBX3 MCM6 RFC3 SEPTIN6 GMPS KIN LMNB1 SMC3 CSNK2A1 BUB1B CD47 CBX1 | 1.12e-08 | 426 | 163 | 16 | M9516 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | VLDLR MAN2A2 ABR MYO5A DSP MAFA FBXO17 COPS2 FAM200B ALKBH5 PPL SOCS2 USF3 TIAM1 KCNH2 RABEP1 PDE4DIP KCNK3 ETNK1 UBE3C RAB39B DNAH5 DYNC1H1 | 2.42e-08 | 946 | 163 | 23 | M39169 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 1.06e-07 | 168 | 163 | 10 | M18811 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | CUL3 ERCC6L DSP SPTBN1 CBX3 GMPS NEK2 SMC3 CBX5 CSNK2A1 BUB1B | 5.10e-07 | 250 | 163 | 11 | M11318 |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 5.35e-07 | 200 | 163 | 10 | M5901 | |
| Coexpression | FISCHER_DREAM_TARGETS | CUL3 NEMP1 ERCC6L POLE SMC1A CCDC18 CBX3 E2F2 MCM6 G2E3 ZNFX1 RFC3 ZRANB3 NEK2 LONP1 LMNB1 SMC3 CBX5 BUB1B CEP295 ATF4 | 6.85e-07 | 969 | 163 | 21 | M149 |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 7.71e-07 | 118 | 163 | 8 | M15305 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | NEMP1 POLE CCDC18 E2F2 MCM6 ARMH1 G2E3 LMNB2 RFC3 DPM1 GMPS NEK2 LMNB1 CBX5 PHACTR4 BUB1B RBM15B CBX1 PRPF19 CEP295 | 1.68e-06 | 939 | 163 | 20 | M45768 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 4.57e-06 | 199 | 163 | 9 | M5893 | |
| Coexpression | GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP | 4.76e-06 | 200 | 163 | 9 | M4344 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NEMP1 POLE SMC1A CBX3 MCM6 LMNB2 RFC3 DPM1 HIRA GMPS LMNB1 SMC3 CSNK2A1 BUB1B CD47 KRT20 PRPF19 | 5.73e-06 | 761 | 163 | 17 | M11961 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CUL3 CLSTN3 OGT MAN2A2 OFD1 MYO5A MYO7A SLC26A2 CBX3 DAXX ZNFX1 VPS26A GIMAP7 ARID1A SEPTIN6 PPP4R3A EEF1G SMC3 SYTL3 PDE4DIP CD47 HELZ PLCB2 DYNC1H1 SH3BGRL3 | 5.86e-06 | 1492 | 163 | 25 | M40023 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DOCK4 NEMP1 COL5A2 FRAS1 ERCC6L SMC1A CCDC18 CBX3 MCM6 LMNB2 FAM200A RFC3 COPS2 GMPS SOCS2 NEK2 LMNB1 CBX5 BUB1B CBX1 ETNK1 ATF4 UBE3C | 2.13e-05 | 1407 | 163 | 23 | M14427 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NEMP1 ERCC6L POLE CCDC18 CBX3 E2F2 MCM6 LMNB2 RFC3 ZRANB3 HIRA NEK2 LMNB1 BUB1B | 2.34e-05 | 597 | 163 | 14 | MM1309 |
| Coexpression | DELYS_THYROID_CANCER_UP | COL5A2 SLC26A3 ABR DSP TRPC5 MAP3K6 PPL CFB TIAM1 PLXNC1 ALOX5 EPHA4 | 2.38e-05 | 445 | 163 | 12 | M3645 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 COL5A2 VLDLR OGT HIRA GMPS KIN LMNB1 TIAM1 SMC3 CSNK2A1 BUB1B NAV3 HELZ PRKCI FERMT2 EPHA4 | 2.60e-05 | 856 | 163 | 17 | M4500 |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | NEMP1 PNKP ERCC6L MYO7A DSP MCM6 PSMD12 RFC3 NEK2 LMNB1 CBX5 BUB1B | 3.16e-05 | 458 | 163 | 12 | M8520 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | CUL3 RBMXL1 MYO5A RUNDC3B MCM6 G2E3 PSMD12 ARID1A COPS2 GMPS BROX NEK2 SMC3 CBX5 CBX1 CPLANE1 FERMT2 | 3.52e-05 | 877 | 163 | 17 | M2241 |
| Coexpression | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP | 3.61e-05 | 258 | 163 | 9 | M4680 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 3.78e-05 | 200 | 163 | 8 | M4622 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 3.78e-05 | 200 | 163 | 8 | M8081 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 3.78e-05 | 200 | 163 | 8 | M8690 | |
| Coexpression | HALLMARK_E2F_TARGETS | 3.78e-05 | 200 | 163 | 8 | M5925 | |
| Coexpression | GOZGIT_ESR1_TARGETS_UP | 4.23e-05 | 149 | 163 | 7 | M13944 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | FRAS1 RBMXL1 POLE SMC1A MCM6 G2E3 RFC3 GMPS TIAM1 SMC3 CBX5 BUB1B CBX1 | 4.68e-05 | 555 | 163 | 13 | M2343 |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 5.01e-05 | 153 | 163 | 7 | M5588 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | TPM4 NEMP1 CBX3 BCHE MCM6 LMNB2 FAM200B GMPS LONP1 LMNB1 SMC3 CBX5 BUB1B FERMT2 | 5.32e-05 | 644 | 163 | 14 | M10501 |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 5.44e-05 | 155 | 163 | 7 | MM1259 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | HEXA NEMP1 LILRA1 OGT OFD1 POLE SMC1A CBX3 MCM6 RFC3 DPM1 HIRA LMNB1 TIAM1 SMC3 RABEP1 CSNK2A1 CD47 KRT20 PRPF19 ALOX5 RPL11 | 5.54e-05 | 1394 | 163 | 22 | M9585 |
| Coexpression | PATIL_LIVER_CANCER | COL5A2 OGT DSP SLC26A2 E2F2 MCM6 LMNB2 MYO5C NEK2 PLXNC1 CD47 CBX1 PYGB DYNC1H1 | 6.91e-05 | 660 | 163 | 14 | M1195 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL | LILRA1 INPP5B CDH23 MCM6 DAXX LMNB2 RFC3 GMPS LMNB1 CBX5 CPLANE1 BANK1 HOMEZ | 7.05e-05 | 578 | 163 | 13 | M45744 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NEMP1 ERCC6L POLE CCDC18 E2F2 MCM6 LMNB2 RFC3 ZRANB3 HIRA NEK2 LMNB1 BUB1B | 7.05e-05 | 578 | 163 | 13 | M2368 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL5A2 KRT12 PNKP OFD1 MYO5A MYO7A TOM1 PSMD12 RFC3 DPM1 MYO5C SOCS2 CCDC13 LMNB1 RABEP1 CSNK2A1 KRT20 ETNK1 ALOX5 | 8.74e-05 | 1136 | 163 | 19 | M2247 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 8.88e-05 | 290 | 163 | 9 | M45736 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | RUNDC3B POLE CCDC18 MCM6 G2E3 ZRANB3 GREB1L GMPS NEK2 RUNDC3A CBX5 BUB1B RBM15B RAB39B | 9.48e-05 | 680 | 163 | 14 | MM456 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.15e-04 | 300 | 163 | 9 | M8702 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | NEMP1 POLE CCDC18 E2F2 MCM6 G2E3 LMNB2 VPS26A RFC3 GMPS LMNB1 CBX5 BUB1B CEP295 | 1.17e-04 | 694 | 163 | 14 | M45767 |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | NEMP1 VLDLR KRT12 OGT RUNDC3B CBX3 E2F2 PSMD12 NDUFA2 SEPTIN6 KIN PLXNC1 CBX1 ATF4 | 1.38e-04 | 705 | 163 | 14 | M1410 |
| Coexpression | ABRAMSON_INTERACT_WITH_AIRE | 1.61e-04 | 44 | 163 | 4 | M2536 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | COL5A2 OGT E2F2 HIRA GMPS TIAM1 BUB1B HELZ PRKCI FERMT2 EPHA4 | 1.70e-04 | 466 | 163 | 11 | M13522 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | COL5A2 KRT12 PNKP OFD1 MYO5A MYO7A TOM1 PSMD12 RFC3 DPM1 MYO5C SOCS2 CCDC13 LMNB1 RABEP1 CSNK2A1 KRT20 ETNK1 ALOX5 | 1.74e-04 | 1198 | 163 | 19 | MM1062 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.76e-04 | 187 | 163 | 7 | M2984 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_DN | 1.94e-04 | 253 | 163 | 8 | M16010 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 2.00e-04 | 323 | 163 | 9 | M2156 | |
| Coexpression | FUJII_YBX1_TARGETS_DN | 2.20e-04 | 194 | 163 | 7 | M14340 | |
| Coexpression | P53_DN.V1_DN | 2.20e-04 | 194 | 163 | 7 | M2697 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 2.27e-04 | 195 | 163 | 7 | M4195 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BASOPHIL_UP | 2.34e-04 | 196 | 163 | 7 | M5413 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN | 2.41e-04 | 197 | 163 | 7 | M8561 | |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP | 2.49e-04 | 198 | 163 | 7 | M5580 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP | 2.57e-04 | 199 | 163 | 7 | M9419 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 2.57e-04 | 199 | 163 | 7 | M6987 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | 2.65e-04 | 200 | 163 | 7 | M8048 | |
| Coexpression | GSE27786_NKCELL_VS_MONO_MAC_DN | 2.65e-04 | 200 | 163 | 7 | M4863 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN | 2.65e-04 | 200 | 163 | 7 | M7186 | |
| Coexpression | GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 2.65e-04 | 200 | 163 | 7 | M8482 | |
| Coexpression | GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN | 2.65e-04 | 200 | 163 | 7 | M7642 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 2.65e-04 | 200 | 163 | 7 | M5286 | |
| Coexpression | GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN | 2.65e-04 | 200 | 163 | 7 | M7873 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.65e-04 | 200 | 163 | 7 | M9122 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 2.90e-04 | 203 | 163 | 7 | MM3795 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 2.98e-04 | 341 | 163 | 9 | M2879 | |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 3.12e-04 | 146 | 163 | 6 | M9372 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | POLE SMC1A CCDC18 E2F2 MCM6 G2E3 PSMD12 LMNB2 RFC3 FAM200B DPM1 GMPS NEK2 LMNB1 CBX5 BUB1B RBM15B CBX1 PRPF19 CEP295 | 3.22e-04 | 1363 | 163 | 20 | M45782 |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP | 3.33e-04 | 53 | 163 | 4 | M4448 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP | 4.15e-04 | 154 | 163 | 6 | M3766 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_T7 | 4.28e-04 | 101 | 163 | 5 | M1731 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_T7 | 4.28e-04 | 101 | 163 | 5 | MM723 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | CUL3 DDX19B NEMP1 ERCC6L E2F2 MCM6 G2E3 RFC3 ALKBH5 ZRANB3 NEK2 LMNB1 SMC3 CSNK2A1 BUB1B KCNK3 ETNK1 USP6NL FRMD5 | 4.38e-04 | 1290 | 163 | 19 | M80 |
| Coexpression | JIANG_HYPOXIA_CANCER | 4.71e-04 | 58 | 163 | 4 | M7547 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 4.72e-04 | 289 | 163 | 8 | M2196 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | TPM4 NEMP1 MAN2A2 TENT4A ERCC6L SLC26A2 SPTBN1 CCDC18 MCM6 G2E3 LMNB2 RNASEL LMNB1 BUB1B CEP295 | 4.73e-04 | 892 | 163 | 15 | M18120 |
| Coexpression | PETROVA_PROX1_TARGETS_UP | 4.91e-04 | 25 | 163 | 3 | M1495 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPM4 CUL3 OFD1 ERCC6L PPFIBP2 POLE SMC1A BCHE G2E3 ARID1A COPS2 DPM1 PPP4R3A GREB1L GMPS RNASEL KIN SMC3 RABEP1 CSNK2A1 CBX1 CEP295 CPLANE1 EPHA4 | 2.06e-05 | 1252 | 159 | 24 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | NEMP1 ERCC6L POLE CCDC18 E2F2 G2E3 ZRANB3 NEK2 LMNB1 SYTL3 CBX5 BUB1B | 4.78e-05 | 398 | 159 | 12 | GSM399397_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | ERCC6L POLE CCDC18 E2F2 MCM6 RFC3 ZRANB3 SOCS2 NEK2 LMNB1 CBX5 BUB1B | 6.20e-05 | 409 | 159 | 12 | GSM399452_500 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | ERCC6L POLE CCDC18 E2F2 MCM6 G2E3 RFC3 ZRANB3 NEK2 LMNB1 CBX5 BUB1B | 7.46e-05 | 417 | 159 | 12 | GSM399403_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | POLE CCDC18 CBX3 MCM6 G2E3 RFC3 ZRANB3 NEK2 LMNB1 CBX5 BUB1B BANK1 | 8.35e-05 | 422 | 159 | 12 | GSM538355_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 9.04e-05 | 97 | 159 | 6 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 3.33e-09 | 198 | 163 | 10 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-08 | 192 | 163 | 9 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-08 | 192 | 163 | 9 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.61e-08 | 200 | 163 | 9 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.61e-08 | 200 | 163 | 9 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.33e-07 | 171 | 163 | 8 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.23e-07 | 185 | 163 | 8 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.18e-07 | 190 | 163 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | facs-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 192 | 163 | 8 | 1f81b356520b5506051383d37fae204d59795336 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.84e-07 | 193 | 163 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-07 | 194 | 163 | 8 | 842636fcc64eb8f04eb4e30b6eb70410050880e9 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-07 | 195 | 163 | 8 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.10e-07 | 136 | 163 | 7 | a2063abe2d7c3277bfbe1514c8c66363cf04b248 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.35e-07 | 199 | 163 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-07 | 137 | 163 | 7 | 8e2fa2ef8becace96a68bb85c002329110902fbb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.64e-07 | 200 | 163 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.71e-06 | 155 | 163 | 7 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-06 | 162 | 163 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.80e-06 | 167 | 163 | 7 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.03e-06 | 169 | 163 | 7 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 169 | 163 | 7 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-06 | 174 | 163 | 7 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-06 | 176 | 163 | 7 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 177 | 163 | 7 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-06 | 178 | 163 | 7 | 79823d13652177de852c2acce9159049241f1d86 | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-06 | 181 | 163 | 7 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-06 | 181 | 163 | 7 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-06 | 185 | 163 | 7 | 282b3de8850f3c21704339e8d8737b432a43441a | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 6.33e-06 | 189 | 163 | 7 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.33e-06 | 189 | 163 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.55e-06 | 190 | 163 | 7 | cd37ccd30c27cf65eda0a9165f35b7672f5acaf6 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 191 | 163 | 7 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 191 | 163 | 7 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 6.78e-06 | 191 | 163 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.02e-06 | 192 | 163 | 7 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 192 | 163 | 7 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | 390C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-06 | 192 | 163 | 7 | 201d430af1e4fee7bc03baf0aca17db26f6f439a | |
| ToppCell | 390C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-06 | 192 | 163 | 7 | 15c1a0a0d07106118427135f166a1da710bf621a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.51e-06 | 194 | 163 | 7 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.51e-06 | 194 | 163 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 7.51e-06 | 194 | 163 | 7 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.51e-06 | 194 | 163 | 7 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.51e-06 | 194 | 163 | 7 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.51e-06 | 194 | 163 | 7 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 7.51e-06 | 194 | 163 | 7 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.51e-06 | 194 | 163 | 7 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.76e-06 | 195 | 163 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-06 | 195 | 163 | 7 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-06 | 196 | 163 | 7 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 8.03e-06 | 196 | 163 | 7 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-06 | 196 | 163 | 7 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-06 | 196 | 163 | 7 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-06 | 196 | 163 | 7 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.03e-06 | 196 | 163 | 7 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.03e-06 | 196 | 163 | 7 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.03e-06 | 196 | 163 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-06 | 196 | 163 | 7 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.03e-06 | 196 | 163 | 7 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 197 | 163 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 8.30e-06 | 197 | 163 | 7 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.30e-06 | 197 | 163 | 7 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.30e-06 | 197 | 163 | 7 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.57e-06 | 198 | 163 | 7 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.57e-06 | 198 | 163 | 7 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.86e-06 | 199 | 163 | 7 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 8.86e-06 | 199 | 163 | 7 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.86e-06 | 199 | 163 | 7 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.86e-06 | 199 | 163 | 7 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.86e-06 | 199 | 163 | 7 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.86e-06 | 199 | 163 | 7 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.86e-06 | 199 | 163 | 7 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 8.86e-06 | 199 | 163 | 7 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.86e-06 | 199 | 163 | 7 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-06 | 200 | 163 | 7 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.15e-06 | 200 | 163 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.15e-06 | 200 | 163 | 7 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 9.15e-06 | 200 | 163 | 7 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-06 | 200 | 163 | 7 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 9.15e-06 | 200 | 163 | 7 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.15e-06 | 200 | 163 | 7 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | severe-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.15e-06 | 200 | 163 | 7 | d341f4e500377a5bef82c24bf64704b981053336 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.15e-06 | 200 | 163 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 9.15e-06 | 200 | 163 | 7 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.15e-06 | 200 | 163 | 7 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.15e-06 | 200 | 163 | 7 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.15e-06 | 200 | 163 | 7 | 5b014c658eecc5e73679e5feb7a2aaa3d297001d | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.46e-05 | 143 | 163 | 6 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 1.92e-05 | 150 | 163 | 6 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 153 | 163 | 6 | 0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 93 | 163 | 5 | 312291db0fab96952017f9faf2057c28f3719556 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 93 | 163 | 5 | 4eca07c288fe15531a685522c61746671c1c87fb | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 93 | 163 | 5 | 8f65381291fc92b56bf0fc2caac013a54560737b | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 157 | 163 | 6 | 14c4c61790eba6a388679e6d5011424d56cf3b5a | |
| Computational | Genes in the cancer module 198. | TENT4A DSP POLE MCM6 PSMD12 RFC3 COPS2 NEK2 LMNB1 CBX5 CSNK2A1 CBX1 ATF4 | 2.45e-05 | 303 | 117 | 13 | MODULE_198 |
| Computational | TFs and nuclear. | TENT4A DSP MCM6 PSMD12 RFC3 COPS2 NEK2 LMNB1 CBX5 CSNK2A1 CBX1 | 5.27e-05 | 237 | 117 | 11 | MODULE_252 |
| Computational | Response to DNA damage. | 1.98e-04 | 187 | 117 | 9 | MODULE_244 | |
| Computational | Genes in the cancer module 98. | TENT4A DSP POLE MCM6 PSMD12 RFC3 COPS2 NEK2 LMNB1 CBX5 CSNK2A1 CBX1 ATF4 | 3.36e-04 | 393 | 117 | 13 | MODULE_98 |
| Drug | magnesium | TPM4 DDX19B DNAH3 PNKP MYO5A MYO7A SMC1A SPTBN1 BCHE DPM1 CFB MYO5C GMPS SLC12A1 PIK3CA KCNH2 RABEP1 CSNK2A1 PKLR CD47 PRKCI PLCB2 PLD1 DNAH5 DNAH9 ALOX5 IL6 DYNC1H1 RPL11 | 5.77e-08 | 1325 | 162 | 29 | CID000000888 |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A | MYO7A INPP5B TRPC5 ALS2CL PPP4R3A RUNDC3A KCNH2 PDGFD CD47 CPLANE1 | 1.48e-06 | 196 | 162 | 10 | 1497_UP |
| Drug | NSC34533 | 2.30e-06 | 54 | 162 | 6 | CID000003512 | |
| Drug | geldanamycin | TPM4 VLDLR MYO5A INPP5A SMC1A SPTBN1 PIK3CA KCNH2 RABEP1 CSNK2A1 PDE4DIP SRRM2 IL6 | 2.70e-06 | 371 | 162 | 13 | ctd:C001277 |
| Drug | AC1L1IZE | 4.55e-06 | 131 | 162 | 8 | CID000004799 | |
| Drug | mantATP | 4.68e-06 | 35 | 162 | 5 | CID000123756 | |
| Drug | Biliton | 1.04e-05 | 41 | 162 | 5 | CID000002974 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | TPM4 OGT ABR ANK1 ACACB ERCC6L INPP5A POLE CDH23 E2F2 MCM6 G2E3 NDUFA2 RFC3 ARID1A GMPS SOCS2 NEK2 KIN LMNB1 PLXNC1 PDE4DIP BUB1B CEP295 MDGA1 IL6 | 1.07e-05 | 1441 | 162 | 26 | ctd:C009828 |
| Drug | AC1NPJ0T | 1.09e-05 | 20 | 162 | 4 | CID005159168 | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.13e-05 | 195 | 162 | 9 | 6661_DN | |
| Drug | AC1L19O6 | 1.64e-05 | 156 | 162 | 8 | CID000025750 | |
| Drug | 2,4,4'-trichlorobiphenyl | TPM4 OGT ABR ANK1 ACACB ERCC6L INPP5A POLE CDH23 E2F2 MCM6 G2E3 NDUFA2 RFC3 ARID1A GMPS SOCS2 NEK2 KIN LMNB1 PLXNC1 PDE4DIP BUB1B CEP295 MDGA1 | 2.20e-05 | 1411 | 162 | 25 | ctd:C081766 |
| Drug | Antigens, Polyomavirus Transforming | ERCC6L SMC1A SPTBN1 RPS9 MCM6 DAXX G2E3 ARID1A ZRANB3 EEF1G USF3 LMNB1 PDE4DIP ETNK1 PRKCI PLD1 | 2.38e-05 | 668 | 162 | 16 | ctd:D000952 |
| Drug | Mercuric Chloride | ACACB MYO5A SMC1A SPTBN1 TRPC5 RPS9 BCHE VPS26A NSUN2 ALKBH5 CFB EEF1G SLC12A1 LMNB1 KCNH2 PKLR KCNK3 ATF4 IL6 DYNC1H1 RPL11 HOMEZ | 2.46e-05 | 1155 | 162 | 22 | ctd:D008627 |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 3.03e-06 | 6 | 159 | 3 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Embryonal Rhabdomyosarcoma | 8.43e-06 | 8 | 159 | 3 | C0206656 | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 8.63e-05 | 3 | 159 | 2 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 8.63e-05 | 3 | 159 | 2 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 8.63e-05 | 3 | 159 | 2 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 8.63e-05 | 3 | 159 | 2 | DOID:0070247 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.56e-04 | 148 | 159 | 6 | C0279702 | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 1.72e-04 | 4 | 159 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | sorting nexin-7 measurement | 1.72e-04 | 4 | 159 | 2 | EFO_0803094 | |
| Disease | Hereditary Diffuse Gastric Cancer | 2.00e-04 | 293 | 159 | 8 | C1708349 | |
| Disease | Stomach Neoplasms | 2.19e-04 | 297 | 159 | 8 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 2.34e-04 | 300 | 159 | 8 | C0024623 | |
| Disease | Usher syndrome, type 1A | 2.85e-04 | 5 | 159 | 2 | C2931205 | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 2.85e-04 | 5 | 159 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 2.85e-04 | 5 | 159 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 2.85e-04 | 5 | 159 | 2 | C4551851 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 2.85e-04 | 5 | 159 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 2.85e-04 | 5 | 159 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 2.85e-04 | 5 | 159 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 2.85e-04 | 5 | 159 | 2 | cv:C1568247 | |
| Disease | Ciliopathies | 3.31e-04 | 110 | 159 | 5 | C4277690 | |
| Disease | thymidine kinase, cytosolic measurement | 4.27e-04 | 6 | 159 | 2 | EFO_0020773 | |
| Disease | De Lange syndrome | 4.27e-04 | 6 | 159 | 2 | cv:C0270972 | |
| Disease | transcription factor AP-1 measurement | 4.27e-04 | 6 | 159 | 2 | EFO_0021909 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 4.27e-04 | 6 | 159 | 2 | EFO_0021905 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 4.27e-04 | 6 | 159 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | Usher Syndrome, Type I | 4.27e-04 | 6 | 159 | 2 | C1568247 | |
| Disease | DNA-binding protein SATB2 measurement | 4.27e-04 | 6 | 159 | 2 | EFO_0802484 | |
| Disease | Colorectal Carcinoma | DNAH3 CLSTN3 POLE LMNB2 ARID1A TIAM1 PIK3CA CBX5 PDGFD BUB1B MMRN2 KRT20 | 4.44e-04 | 702 | 159 | 12 | C0009402 |
| Disease | Prostatic Neoplasms | CUL3 ABR PPFIBP2 ARID1A PPL RNASEL PIK3CA CBX1 ALOX5 IL6 RPL11 | 5.37e-04 | 616 | 159 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | CUL3 ABR PPFIBP2 ARID1A PPL RNASEL PIK3CA CBX1 ALOX5 IL6 RPL11 | 5.37e-04 | 616 | 159 | 11 | C0376358 |
| Disease | Squamous cell carcinoma | 5.73e-04 | 124 | 159 | 5 | C0007137 | |
| Disease | Hereditary retinal dystrophy | 5.95e-04 | 7 | 159 | 2 | C0154860 | |
| Disease | Usher syndrome | 5.95e-04 | 7 | 159 | 2 | cv:C0271097 | |
| Disease | Severe Congenital Microcephaly | 6.18e-04 | 31 | 159 | 3 | C3853041 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.62e-04 | 128 | 159 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.62e-04 | 128 | 159 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.62e-04 | 128 | 159 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 6.62e-04 | 128 | 159 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 6.62e-04 | 128 | 159 | 5 | C0007134 | |
| Disease | Microlissencephaly | 7.44e-04 | 33 | 159 | 3 | C1956147 | |
| Disease | Unilateral agenesis of kidney | 7.91e-04 | 8 | 159 | 2 | C0266294 | |
| Disease | Cornelia De Lange Syndrome | 7.91e-04 | 8 | 159 | 2 | C0270972 | |
| Disease | progeria (implicated_via_orthology) | 7.91e-04 | 8 | 159 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | Middle Cerebral Artery Embolus | 8.13e-04 | 34 | 159 | 3 | C0751845 | |
| Disease | Embolic Infarction, Middle Cerebral Artery | 8.13e-04 | 34 | 159 | 3 | C0751847 | |
| Disease | Left Middle Cerebral Artery Infarction | 8.13e-04 | 34 | 159 | 3 | C0751846 | |
| Disease | Right Middle Cerebral Artery Infarction | 8.13e-04 | 34 | 159 | 3 | C0751849 | |
| Disease | Thrombotic Infarction, Middle Cerebral Artery | 8.13e-04 | 34 | 159 | 3 | C0751848 | |
| Disease | Middle Cerebral Artery Occlusion | 8.13e-04 | 34 | 159 | 3 | C0740391 | |
| Disease | Infarction, Middle Cerebral Artery | 8.13e-04 | 34 | 159 | 3 | C0740392 | |
| Disease | Middle Cerebral Artery Thrombosis | 8.13e-04 | 34 | 159 | 3 | C0740376 | |
| Disease | Middle Cerebral Artery Syndrome | 8.13e-04 | 34 | 159 | 3 | C0238281 | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | malaria (implicated_via_orthology) | 1.01e-03 | 9 | 159 | 2 | DOID:12365 (implicated_via_orthology) | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 1.01e-03 | 9 | 159 | 2 | EFO_0010613 | |
| Disease | Disorder of eye | 1.05e-03 | 212 | 159 | 6 | C0015397 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.17e-03 | 85 | 159 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | interleukin-37 measurement | 1.26e-03 | 10 | 159 | 2 | EFO_0020506 | |
| Disease | glucagon-like peptide-1 measurement | 1.26e-03 | 10 | 159 | 2 | EFO_0008465 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.49e-03 | 227 | 159 | 6 | EFO_0004346, EFO_0010736 | |
| Disease | volumetric bone mineral density | 1.51e-03 | 42 | 159 | 3 | EFO_0007620 | |
| Disease | beta thalassemia (is_marker_for) | 1.54e-03 | 11 | 159 | 2 | DOID:12241 (is_marker_for) | |
| Disease | Hemolytic-Uremic Syndrome | 1.54e-03 | 11 | 159 | 2 | C0019061 | |
| Disease | Chagas cardiomyopathy | 1.73e-03 | 44 | 159 | 3 | EFO_0005529 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.84e-03 | 12 | 159 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | autistic disorder (is_marker_for) | 1.84e-03 | 12 | 159 | 2 | DOID:12849 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | ZNF438 TPM4 ANK1 MYOD1 RPS9 BCHE NDUFA2 ARID1A ALS2CL MAP3K6 PIK3CA OTOGL DNAH9 IL6 | 2.08e-03 | 1074 | 159 | 14 | C0006142 |
| Disease | Primary Ciliary Dyskinesia | 2.09e-03 | 47 | 159 | 3 | C4551720 | |
| Disease | Adenoid Cystic Carcinoma | 2.13e-03 | 100 | 159 | 4 | C0010606 | |
| Disease | Seizures, Focal | 2.46e-03 | 104 | 159 | 4 | C0751495 | |
| Disease | Malformations of Cortical Development | 2.52e-03 | 14 | 159 | 2 | C1955869 | |
| Disease | Adenocarcinoma Of Esophagus | 2.52e-03 | 14 | 159 | 2 | C0279628 | |
| Disease | Cortical Dysplasia | 2.52e-03 | 14 | 159 | 2 | C0431380 | |
| Disease | eosinophil count | DNAH3 TENT4A SPTBN1 CCDC18 E2F2 RSPH6A FBXO17 ITIH4 CCDC13 RUNDC3A PLXNC1 RABEP1 ZC3H12D PRKCI PLD1 PEAK1 IL6 | 2.85e-03 | 1488 | 159 | 17 | EFO_0004842 |
| Disease | Situs ambiguus | 2.89e-03 | 15 | 159 | 2 | C0266642 | |
| Disease | Rhabdomyosarcoma | 2.89e-03 | 15 | 159 | 2 | C0035412 | |
| Disease | Metastatic melanoma | 3.11e-03 | 54 | 159 | 3 | C0278883 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 3.11e-03 | 54 | 159 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | teratocarcinoma-derived growth factor 1 measurement | 3.29e-03 | 16 | 159 | 2 | EFO_0008297 | |
| Disease | p-cresol sulfate measurement | 3.29e-03 | 16 | 159 | 2 | EFO_0010998 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 3.29e-03 | 16 | 159 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Carcinoma, Granular Cell | 3.64e-03 | 116 | 159 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.64e-03 | 116 | 159 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.64e-03 | 116 | 159 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.64e-03 | 116 | 159 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.64e-03 | 116 | 159 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.64e-03 | 116 | 159 | 4 | C0001418 | |
| Disease | Benign neoplasm of stomach | 3.72e-03 | 17 | 159 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.72e-03 | 17 | 159 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 3.72e-03 | 17 | 159 | 2 | C0154060 | |
| Disease | Fetal Alcohol Syndrome | 3.72e-03 | 17 | 159 | 2 | C0015923 | |
| Disease | Polydactyly | 3.75e-03 | 117 | 159 | 4 | C0152427 | |
| Disease | Libman-Sacks Disease | 3.81e-03 | 58 | 159 | 3 | C0242380 | |
| Disease | Carcinoma of bladder | 4.17e-03 | 18 | 159 | 2 | C0699885 | |
| Disease | Myeloid Leukemia | 4.17e-03 | 18 | 159 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 4.17e-03 | 18 | 159 | 2 | C0023466 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.20e-03 | 60 | 159 | 3 | EFO_0022233 | |
| Disease | colorectal cancer (is_implicated_in) | 4.23e-03 | 121 | 159 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Bipolar Disorder | 4.47e-03 | 477 | 159 | 8 | C0005586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VEKRGIEEVGIYRIS | 671 | Q12979 | |
| VVKREAILLYRLENF | 51 | Q8NDB2 | |
| LLERAVEALQGEKRY | 101 | O60566 | |
| REKLEVLERTYGEIE | 851 | Q60I27 | |
| DIFTELERRIVGQYK | 271 | P0CF97 | |
| QGKILSRVYELRNEI | 391 | P0CF97 | |
| YDGKFLARVERVIVV | 156 | P06276 | |
| EGKLYDRILRVEAID | 156 | Q9BQT9 | |
| EREEYGKLQKILRQL | 161 | P61201 | |
| LDRRVVNGKVEYFLK | 36 | Q13185 | |
| LDRRVVKGQVEYLLK | 26 | P45973 | |
| RLVKYEIRAEALVDG | 446 | Q32M84 | |
| RIDEVVSRAEKGLYN | 106 | Q6P6C2 | |
| YGKVRVAELLLERDA | 546 | P16157 | |
| IQYLKDLIEEVRKAR | 331 | P18848 | |
| EAIELIKDLVGYDVR | 241 | Q6PIY5 | |
| IGIYILRDDQRVKIV | 2946 | Q9H251 | |
| QGKVLSRVYELRNEI | 306 | Q8TCP9 | |
| ALYVAEIRRLQEKEL | 196 | Q9UER7 | |
| EQLEKIYGSDRILLR | 76 | O60762 | |
| ILERVDRRLVYKFGK | 241 | Q9UKW6 | |
| ELRLERKKLIEDYEG | 236 | Q8NB25 | |
| RKAIQVREFEYDLLV | 606 | Q96MI9 | |
| TFELVYEELLKRRLG | 141 | Q14624 | |
| VELRRAFEKYGIIEE | 351 | Q8NDT2 | |
| DLTRDIYELVKRGEI | 166 | Q96DA2 | |
| ALRELVLKYREDIIN | 676 | Q15276 | |
| ELKDDYIIRTNRLIE | 356 | O75665 | |
| RREKLALALENEGYI | 156 | Q6IN85 | |
| LKGRRVEGIQYEDIS | 376 | O60870 | |
| IDVDGRKEILFYDRI | 251 | Q08J23 | |
| YGLRRITFLIAQEKE | 1456 | O00763 | |
| RRCLIEIFGILKEYE | 1721 | O14497 | |
| VIDEIRDLLYIGKDR | 401 | P00751 | |
| RRVEKGQLLEYILTD | 696 | Q8NFP4 | |
| DGEIKYLQLAEELIR | 41 | Q14566 | |
| ERGIIYRDLKLDNVL | 371 | P41743 | |
| IYIREDGRLVIEFKT | 3526 | Q86XX4 | |
| LKLEVGRLAKERDLY | 296 | Q8NHW3 | |
| LNVKARLELEIETYR | 416 | Q99456 | |
| GTKERQYLDEEFVLR | 101 | P51955 | |
| QGGYEELERVVLRLK | 56 | O14649 | |
| KLYLDLDVIREGQRD | 496 | Q9H8L6 | |
| YRKLLEGEEERLKLS | 391 | Q03252 | |
| LLGAEERKVEIAFYR | 86 | Q12809 | |
| AYRKLLEGEEERLKL | 376 | P20700 | |
| REGAQRVYIEIKFTL | 91 | P54764 | |
| LREILAGKEREYQAL | 1176 | O95382 | |
| LTDLYRRDETIQVKG | 46 | Q9GZP0 | |
| YFDEILNKLERERGL | 1531 | O60486 | |
| GYVLDRIIDQRFEKV | 211 | Q14642 | |
| RDGGQEYVVKEVLRI | 986 | O60437 | |
| LYRGLENREEVVGKI | 1276 | Q9H792 | |
| KEYFDRKLRVEVLGE | 21 | P51160 | |
| KVEILRNAIRYIEGL | 146 | P15172 | |
| EYRIQGEVETRKALE | 346 | O14524 | |
| DVLDGVIRRLFKEYV | 1951 | Q8IVL0 | |
| KVVQEYERVIIFRLG | 126 | Q9NP85 | |
| RIYIDDGLISLVVQK | 216 | P30613 | |
| LILIDEVDKIGRGYQ | 586 | P36776 | |
| DRLAGYLEKVRQLEQ | 106 | Q92764 | |
| FEVKRRGELQLIKIF | 971 | Q07864 | |
| VTEGKIYVEIERARL | 131 | O00232 | |
| QEVRDKLGLQYRFEI | 976 | Q9C091 | |
| EIATYRRLLEGEDVK | 366 | P35900 | |
| RRLLEGEDVKTTEYQ | 371 | P35900 | |
| EIERIKIESLLYRIA | 51 | P42694 | |
| LLARKILRFNEYVEV | 636 | Q8IZ21 | |
| VNIRDIDKIYVRTGI | 346 | P42336 | |
| KDRRIEELTGLLNQY | 296 | Q8ND30 | |
| LGRIIKVTQEVIDYR | 511 | Q5XG87 | |
| ERRLIEKYIAENGTD | 26 | Q9UMS4 | |
| VYQLRVRLLDVYEKE | 196 | Q96EF6 | |
| AIIERVQRYLEEKGT | 481 | Q99613 | |
| EEITRYLVFLQIKRD | 106 | Q7Z6J6 | |
| VYGFLIEDIRKEVNR | 61 | Q7L622 | |
| LGRKEELLRGYEKDV | 1301 | B1AJZ9 | |
| ELLRGYEKDVEQLRR | 1306 | B1AJZ9 | |
| QYGKVIDRRVRELFV | 36 | P49915 | |
| KRRIYDITNVLEGIQ | 166 | Q14209 | |
| RNDLYITIERGEFEK | 401 | Q8N1I0 | |
| EIEEKGGRRTYFLQI | 856 | Q9H799 | |
| RLGENIIEYSRDFKL | 3156 | Q8TD57 | |
| YKEAIDLGQELRLTR | 1126 | Q5T9S5 | |
| DLQEVKRVLYGKELR | 21 | Q9UBR1 | |
| IKKRIEGLIEREYLA | 741 | Q13618 | |
| VLLQEEGTRKREYEN | 1176 | P15924 | |
| ELRETVDENGRLYKL | 86 | Q8IYE1 | |
| VDENGRLYKLLKERD | 91 | Q8IYE1 | |
| RYKEDDLVKRTLFIN | 231 | Q5T3F8 | |
| ELKLAYAVRGNKLER | 191 | Q9UMR2 | |
| QERVEALYLIGELKL | 711 | Q86WZ0 | |
| VLDRRVVKGKVEYLL | 26 | P83916 | |
| LDIKAEGNIRFRYIV | 1431 | P05997 | |
| QLVRIAKVLGTEDLY | 241 | P68400 | |
| AKEAVVVDYGVRLLR | 576 | P49641 | |
| FDIGVRVVNDELYRK | 636 | P32019 | |
| EYEKLQVLLRDIVKR | 426 | Q14204 | |
| AKEEVRRILGLLDAY | 131 | P26641 | |
| LYVEDRKEVLGQFLL | 1016 | Q9NYC9 | |
| ARREDYQKLEQITGL | 381 | Q8IX15 | |
| REGETIIELKYRVVS | 121 | Q08722 | |
| VRIYGNKTELLVDRD | 166 | Q9HBU6 | |
| LVNEGFEYRLREICK | 946 | P54198 | |
| KKEELIGIAYNRLIR | 581 | Q96AC1 | |
| RRIQELYLSEKENVG | 1121 | Q9C0D2 | |
| TGDIYAIQKLDREER | 96 | Q9H159 | |
| RYGLLIAREEIDKVD | 1286 | Q8TE73 | |
| ERIDKQIRYILDGIS | 51 | P05231 | |
| EEKIYRRQVFKDSLI | 591 | Q2NKX8 | |
| YQVLLDVKARLEGEI | 376 | O76013 | |
| LKILFAIDGERIYIQ | 591 | Q3ZCN5 | |
| IKREQGNIEEAVRLY | 336 | O15294 | |
| GNIEEAVRLYRKALE | 341 | O15294 | |
| LRELYGVGVEKLRIE | 56 | P40938 | |
| AQDVKEVIEYARLRG | 236 | P06865 | |
| QGVRDFIEKRYVELK | 31 | O43678 | |
| GYLEELVRLRESQLK | 266 | Q59EK9 | |
| EQKGYLEELLRLREN | 281 | Q96NL0 | |
| YILGLKIEDFLERRL | 96 | P46781 | |
| IKRSYLVAEVEFREG | 351 | Q9H0K4 | |
| KELEREAILQVLYRD | 11 | Q4VX76 | |
| REFIGKEENILLYKR | 511 | A5PLK6 | |
| EYEQEAERLLVGLIK | 156 | Q9BQS2 | |
| LKLLREVAGTRVYDE | 156 | Q9UQE7 | |
| YGRIVEVLLIKDRET | 31 | Q96E39 | |
| YKGEEELRRLEAALV | 36 | Q9UQ35 | |
| ELGEIQLVRIEKRKY | 61 | P09917 | |
| GILETQEYRLYREKK | 51 | O75019 | |
| EEQYLGLALDVDRIK | 1471 | Q6P3W6 | |
| EEQYLGLALDVDRIK | 2691 | Q6P3W6 | |
| EEQYLGLALDVDRIK | 956 | A0A087WUL8 | |
| EEQYLGLALDVDRIK | 2176 | A0A087WUL8 | |
| EEQYLGLALDVDRIK | 3396 | A0A087WUL8 | |
| FLGRRKQLEDYLTKI | 176 | Q13393 | |
| QGRSKQELVRDYLEL | 206 | Q96MH2 | |
| VLVLLLGRYTEEEQK | 96 | Q8NHV1 | |
| EVKRDLEDLGRLVLY | 516 | Q05823 | |
| RIEYQDGKFRLDSII | 96 | O14508 | |
| LRIYVGGKINRIEEE | 941 | Q13621 | |
| RKLRELEAEGYKLVI | 201 | Q96T60 | |
| LQEFIRIKVDVYIVG | 671 | P40879 | |
| RILDGKRIQYQLVDI | 26 | Q9H299 | |
| FEAYLQEELKIRRVL | 126 | Q14141 | |
| GSEKIRERIIYIREQ | 711 | Q01082 | |
| GIEERYKEVAELTRL | 826 | Q01082 | |
| KGRDLESRLIEAYVI | 171 | Q5VW32 | |
| GNELIRIRKEIFYEL | 446 | Q96M20 | |
| SVEAIGRIYEEQRKL | 256 | Q9NQ89 | |
| LAQERAEIVAKYDRG | 11 | Q92738 | |
| KLALFLRVYEEKREQ | 221 | Q9NUD5 | |
| YEEVARKLVILEGEL | 126 | P67936 | |
| EEDGIRRLYVNSVKE | 866 | Q13009 | |
| EILEKGLKVREYELR | 81 | P62913 | |
| TLKEVRRDYEAIGIQ | 666 | P50443 | |
| GVVTIYEDLRRKGLE | 136 | O60784 | |
| VVGDRLKVIFLENYR | 636 | P11216 | |
| RELKGAKLVIDVIRY | 586 | Q14683 | |
| LEEIQKENGRYIELL | 96 | Q68DE3 | |
| LLRQGEEQYECVLKR | 991 | Q00722 | |
| RYGTSIKQRLEEIEI | 1631 | Q9P2E3 | |
| QKLGYDREDVLRVLG | 11 | A2A288 | |
| IEDSFQKVILRRYEK | 91 | O43345 | |
| IVRRLTDLVKEYDLI | 136 | O75436 | |
| LYAIRKEVVGAVELL | 101 | Q9UL62 | |
| DEILAFQGKRRKYII | 391 | Q7Z4V0 | |
| EERVKIFQRLIYADK | 696 | Q15386 | |
| EAVIENKTRYIRIDG | 356 | Q5FWF4 | |
| IRKIGLERKEYIQLV | 451 | P98155 | |
| IRGAELEYESLKRQE | 1196 | Q9Y4I1 | |
| YRVGDKVLRLLLEDG | 31 | Q9NQX4 | |
| RAGQVAYLEKLRLDK | 741 | Q9NQX4 | |
| REEVLQLGALIYRVK | 2031 | Q13402 | |
| EFRVYGKSENILVLR | 1341 | Q5VU43 |